{
  "meta": {
    "title": "Lab_Reports_Interpretation_Mini_Test_-_Tmt",
    "url": "https://brainandscalpel.vercel.app/lab-reports-interpretation-mini-test-tmt-64e9c2d5.html",
    "scrapedAt": "2025-11-30T12:46:27.422Z"
  },
  "questions": [
    {
      "text": "A patient presents to the OPD with complaints of fatigue and shortness of breath. The laboratory investigations are given below. Which of the following is used in the management of this condition?<div class='question-desc-html'><ul>\n<li>Hemoglobin - Reduced</li>\n<li>Serum ferritin - Raised</li>\n<li>Serum iron - Raised</li>\n<li>Total iron-binding capacity (TIBC) - Normal&nbsp;</li>\n<li>Hemoglobin electrophoresis - Normal</li>\n</ul></div>",
      "choices": [
        {
          "id": 1,
          "text": "Iron supplementation"
        },
        {
          "id": 2,
          "text": "Bone marrow transplantation"
        },
        {
          "id": 3,
          "text": "Pyridoxine supplemenation"
        },
        {
          "id": 4,
          "text": "Folate supplementation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given clinical scenario, laboratory investigations reveal <strong>raised iron</strong> and <strong>ferritin</strong> with <strong>normal TIBC</strong> and <strong>hemoglobin electrophoresis</strong> point toward the diagnosis of <strong>sideroblastic anemia. Vitamin B6&nbsp;</strong>is used in the management.</p>\n<p>Raised iron levels rule out iron deficiency anemia and anemia of chronic disease. Normal hemoglobin electrophoresis rules out thalassemia. Hence the most probable diagnosis in this case is sideroblastic anemia.</p>\n<p><strong>Laboratory findings in sideroblastic anemia:</strong></p>\n<ul>\n<li>Peripheral smear:&nbsp;<strong>Hypochromic</strong>,&nbsp;<strong>microcytic</strong> (sometimes normocytic) anemia</li>\n<li>Absolute values:&nbsp;<strong>MCV, and MCH are</strong><strong>&nbsp;reduced</strong> and <strong>RDW</strong> is <strong>increased</strong></li>\n<li>Bone marrow: <strong>Ring sideroblasts</strong>&nbsp;are present.</li>\n<li>Serum ferritin:&nbsp;<strong>Raised</strong></li>\n<li>Serum iron:&nbsp;<strong>Raised</strong></li>\n<li>TIBC:&nbsp;<strong>Normal</strong></li>\n<li>Haemoglobin electrophoresis:&nbsp;<strong>Normal</strong></li>\n</ul>\n<p><strong>Iron studies&nbsp;</strong></p>\n<ul>\n<li><strong>Serum iron</strong></li>\n</ul>\n<div class=\"page\" title=\"Page 791\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The serum iron level represents the amount of <strong>circulating iron</strong> bound to transferrin.<br /><span>Normal range</span><strong>: </strong><span>50&ndash;150 &mu;g/dL</span></p>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li><strong><span>Ferritin</span></strong></li>\n</ul>\n<p><span>As free <strong>iron</strong> is toxic to cells it is <strong>stored</strong> in the form of <strong>ferritin. Apoferritin binds</strong> to free ferrous <strong>iron</strong> and stores it in a ferric state.&nbsp;<br />Normal values- Adult Males: 100 </span><span>&mu;g/L and adult females: </span><span>30 &mu;g/L</span></p>\n<ul>\n<li><strong><span>Transferrin saturation</span></strong></li>\n</ul>\n<p><span>Transferrin saturation is calculated with the following formula= <strong>serum iron</strong> <strong>x 100/TIBC</strong><br />Normal range: </span><span>25&ndash;50%</span></p>\n<ul>\n<li><strong><span>Total iron binding capacity</span></strong></li>\n</ul>\n<p><span>Iron binding capacity is the <strong>capacity of transferrin</strong> to <strong>bind</strong> with <strong>iron.</strong> Iron binding capacity is of two types, TIBC and unsaturated iron-binding capacity <strong>(UIBC).</strong> When <strong>iron</strong> stores are <strong>depleted,</strong> the <strong>transferrin</strong> levels <strong>increase</strong> in the blood. As only <strong>one-third</strong> of <strong>transferrin</strong> is <strong>saturated</strong> with iron, the transferrin present in serum has an <strong>extra binding capacity</strong> (67%). <strong>This</strong> is <strong>unsaturated iron-binding</strong> capacity. <strong>TIBC</strong> is the <strong>total</strong> of <strong>serum iron</strong> and <strong>UIBC.</strong></span></p>\n<p><span>Normal range: 300&ndash;360 &mu;g/dL.</span></p><hr><h3>Related Pearl: Differential Diagnosis of Microcytic Anaemia</h3><table>\n<tbody>\n<tr>\n<td>Investigation</td>\n<td><strong>Iron- Deficiency Anemia</strong></td>\n<td><strong>Alpha or beta thalassemia</strong></td>\n<td><strong>Anemia of Chronic Disease</strong></td>\n</tr>\n<tr>\n<td><strong>Serum Iron</strong></td>\n<td>&lt;60 &micro;g/dL</td>\n<td>Normal/Increased</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Serum Ferritin</strong></td>\n<td>&lt;20 &micro;g/L</td>\n<td>Normal/Increased</td>\n<td>Increased</td>\n</tr>\n<tr>\n<td><strong>TIBC</strong></td>\n<td>Increased</td>\n<td>Normal</td>\n<td>Decreased</td>\n</tr>\n<tr>\n<td><strong>Transferrin saturation</strong></td>\n<td>&lt;15%</td>\n<td>Normal</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>MCV</strong></td>\n<td>Decreased</td>\n<td>&nbsp;Decreased</td>\n<td>Normal/Decreased</td>\n</tr>\n<tr>\n<td><strong>RBC count</strong></td>\n<td>Decreased</td>\n<td>Normal/Increased</td>\n<td>Normal/Increased</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>TIBC: Total iron-binding capacity&nbsp;</p><hr><h3>Related Pearl: Morphological Classification of Anemias</h3><p> </p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Microcytic Hypochromic </strong></p>\n<p><strong>(MCV &lt;80 fl)</strong></p>\n</td>\n<td>\n<p><strong>Normocytic Normochromic    </strong></p>\n<p><strong>(MCV 80 - 100 fl)</strong></p>\n</td>\n<td>\n<p><strong>Macrocytic Normochromic </strong></p>\n<p><strong>(MCV &gt;100 fl)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Iron deficiency anemia</p>\n<p>Sideroblastic anemia</p>\n<p>Thalassemia</p>\n<p>Lead toxicity</p>\n</td>\n<td>\n<p>Acute blood loss</p>\n<p>Anemia of chronic disease</p>\n<p>Anemia of renal disease</p>\n<p>Hemolysis*</p>\n<p>Bone marrow suppression</p>\n<ul>\n<li>Aplastic anemia</li>\n<li>Pure red cell aplasia</li>\n</ul>\n<p> </p>\n<p>  </p>\n</td>\n<td>\n<p><strong>Megaloblastic:</strong></p>\n<p>Vitamin B12 deficiency</p>\n<p>Folate deficiency</p>\n<p>Thiamine deficiency</p>\n<p>Drugs - Methotrexate, Zidovudine, hydroxyurea</p>\n<p>Orotic aciduria</p>\n<p> </p>\n<p><strong>Non-megaloblastic:</strong></p>\n<p>Alcohol use</p>\n<p>Liver disease</p>\n<p>Hypothyroidism</p>\n<p>Hemolysis*</p>\n<p> </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Hemolysis can be associated with macrocytosis because of compensatory reticulocytosis. However, MCV can be normal depending on the degree of hemolysis.</p>\n<p>Note: In Orotic Aciduria, peripheral blood smear shows Hypochromic megaloblastic anemia. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0196",
      "difficulty": "medium"
    },
    {
      "text": "A 17-year-old boy presented to OPD for routine health checkup. Investigations were performed and are given below. What is the most probable diagnosis?<div class='question-desc-html'><p>Serum bilirubin: 3 mg/dl<br />Direct bilirubin: 0.2 mg/dl<br />Indirect bilirubin: 2.8 mg/dl<br />AST: 40 U/L<br />ALT: 25 U/L</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Dubin-johnson syndrome"
        },
        {
          "id": 2,
          "text": "Rotor syndrome"
        },
        {
          "id": 3,
          "text": "Gilbert syndrome"
        },
        {
          "id": 4,
          "text": "Crigler-Najjar syndrome type II"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given scenario, isolated <strong>elevation of unconjugated (Indirect) bilirubin</strong> in an asymptomatic post-pubertal patient points towards the diagnosis of <strong>Gilbert syndrome.</strong></p>\n<p><strong>Dubin Johnson</strong> and <strong>Rotor syndrome</strong> have <strong>elevated</strong> levels of <strong>conjugated</strong> bilirubin. <strong>Crigler-Najjar</strong> syndrome type II has similar laboratory findings, however, it usually <strong>presents</strong> in the <strong>neonatal period.</strong></p>\n<p><strong>Serum bilirubin </strong>is the <strong>breakdown product</strong> of heme-containing proteins. The normal serum total bilirubin levels are between <strong>1-1.5 mg/dL.</strong> There are two types of bilirubin:</p>\n<ul>\n<li><strong>Conjugated </strong>(Direct) bilirubin: It is <span><strong>water-soluble</strong> and is excreted by the kidney. The <strong>normal</strong> upper limit is <strong>0.3 mg/dl.</strong> Conjugated hyperbilirubinemia is seen in the <strong>liver</strong> or <strong>biliary tract disease.</strong></span></li>\n<li><strong>Unconjugated </strong>(Indirect) bilirubin: <span>Unconjugated bilirubin always binds to albumin in the serum and is not filtered by the kidney.</span> Unconjugated hyperbilirubinemia is seen in <strong>hemolytic anemias</strong>, <strong>Crigler-Najjar, and Gilbert’s syndromes</strong>. </li>\n</ul>\n<p>However, in the majority of liver diseases, both conjugated and unconjugated are elevated.</p>\n<p><strong>Liver enzymes</strong></p>\n<ul>\n<li>Aspartate aminotransferase <strong>(AST): <br /></strong>Normal range: <strong>7-56 U/L</strong><br />AST is found in multiple organs and is a less specific marker.</li>\n<li>Alanine aminotransferase <strong>(ALT):<br /></strong>Normal range: <strong>0 to 35 U/L<br /></strong> ALT is specifically found in the liver and is a more specific indicator of liver injury.</li>\n</ul>\n<p>The AST: ALT ratio can be interpreted as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>AST: ALT</strong></td>\n<td><strong>Condition</strong></td>\n</tr>\n<tr>\n<td>&lt;1</td>\n<td>Chronic viral hepatitis, Non-alcoholic fatty liver disease</td>\n</tr>\n<tr>\n<td>&gt;1</td>\n<td>Cirrhosis</td>\n</tr>\n<tr>\n<td>&gt;2:1</td>\n<td>\n<p>Suggestive of alcoholic liver disease</p>\n<p>Alcohol intake is associated with the deficiency of pyridoxal phosphate, which in turn leads to decreased levels of ALT enzyme. So, AST&gt;ALT.</p>\n</td>\n</tr>\n<tr>\n<td>&gt;3:1</td>\n<td>Highly suggestive of alcoholic liver disease</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Alkaline phosphatase</strong><span> and </span><strong>5<span class=\"s1\">′</span>-nucleotidase </strong><span>are the markers for </span><strong>cholestasis.</strong></li>\n</ul>\n<p><strong>Serum albumin</strong></p>\n<p>Albumin is <strong>synthesized</strong> exclusively by <strong>hepatocytes.</strong> The level of albumin decreases in decreased liver function. However, the half-life of albumin is 18-20 days. Therefore it is <strong>not</strong> a <strong>good indicator</strong> of acute or <strong>mild</strong> hepatic <strong>dysfunction</strong> like viral hepatitis, drug-induced hepatotoxicity, etc. It mainly <strong>indicates chronic</strong> hepatic <strong>dysfunction.</strong></p>\n<p><strong>Serum globulins</strong></p>\n<p>Serum globulins include <span><strong>γ</strong> </span>globulin produced by <span>B lymphocytes and <strong>α and β globulins</strong> produced primarily in hepatocytes. </span><span>γ Globulins are <strong>increased</strong> in chronic liver diseases, such as chronic <strong>hepatitis</strong> and <strong>cirrhosis.</strong></span></p>\n<p><strong>Coagulation factors</strong></p>\n<p>All the blood clotting factors are synthesized in the liver except factor VIII. In contrast to albumin, they have a very <strong>short half-life. </strong>Therefore, it can be helpful in <strong>diagnosing acute</strong> parenchymal <strong>diseases.</strong></p><hr><h3>Related Pearl: Laboratory Evaluation of Liver Disease</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Test Category</strong></p>\n</td>\n<td>\n<p><strong>Serum measurement</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatocyte integrity</p>\n</td>\n<td>\n<p><strong>Cytosolic hepatocellular enzymes</strong></p>\n<p>Serum aspartate aminotransferase (AST)</p>\n<p>Serum alanine aminotransferase (ALT)</p>\n<p>Serum lactate dehydrogenase (LDH)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biliary excretory function</p>\n</td>\n<td>\n<p><strong>Substances normally secreted in bile</strong></p>\n<p>Serum bilirubin</p>\n<ul>\n<li>Total: unconjugated plus conjugated</li>\n<li>Direct: conjugated only</li>\n</ul>\n<p>Urine bilirubin</p>\n<p>Serum bile acids</p>\n<p><strong>Plasma membrane enzymes (from damage to bile canaliculus)</strong></p>\n<p>Serum alkaline phosphatase</p>\n<p>Serum &gamma;-glutamyl transpeptidase (GGT)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hepatocyte synthetic function</p>\n</td>\n<td>\n<p><strong>Proteins secreted into the blood</strong></p>\n<p>Serum albumin</p>\n<p>Coagulation factors:</p>\n<p>Prothrombin (PT) and partial thromboplastin time (PTT) (fibrinogen, prothrombin, factors V, VII, IX, and X)</p>\n<p><strong>Hepatocyte metabolism</strong></p>\n<p>Serum ammonia</p>\n<p>Aminopyrine breath test (hepatic demethylation)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Principal Serum Enzymes Used in Clinical Diagnosis</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;<strong>Serum Enzyme</strong></td>\n<td><strong>Major Diagnostic Use/Location</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\">Aminotransferases&nbsp;</td>\n</tr>\n<tr>\n<td>Aspartate aminotransferase (AST/SGOT)</td>\n<td>Liver function</td>\n</tr>\n<tr>\n<td>Alanine aminotransferase (ALT/SGPT)</td>\n<td>Viral hepatitis</td>\n</tr>\n<tr>\n<td colspan=\"2\">Creatine kinase</td>\n</tr>\n<tr>\n<td>CK-MM</td>\n<td>Skeletal muscle,&nbsp;Muscle disorders</td>\n</tr>\n<tr>\n<td>CK-BB</td>\n<td>Brain,&nbsp;Brain injury, meningitis, abnormal cell growth, severe shock, stroke, hypothermia, or restricted blood flow to the bowel.</td>\n</tr>\n<tr>\n<td>CK-MB</td>\n<td>Heart and skeletal muscle, Myocardial Infarction, Muscular dystrophy</td>\n</tr>\n<tr>\n<td colspan=\"2\">Lactate dehydrogenase (LDH)</td>\n</tr>\n<tr>\n<td>HHHH (I<sub>1</sub>)/LDH-1</td>\n<td>Heart &amp; RBC;Myocardial infarction</td>\n</tr>\n<tr>\n<td>HHHM(I<sub>2</sub>)/LDH-2</td>\n<td>Reticuloendothelial system</td>\n</tr>\n<tr>\n<td>HHMM(I<sub>3</sub>)/LDH-3</td>\n<td>Lungs</td>\n</tr>\n<tr>\n<td>HMMM(I<sub>4</sub>)/LDH-4</td>\n<td>Liver &amp; Skeletal Muscles</td>\n</tr>\n<tr>\n<td>MMMM(I<sub>5</sub>)/LDH-5</td>\n<td>Liver &amp; Skeletal Muscles; Liver diseases</td>\n</tr>\n<tr>\n<td colspan=\"2\">Others</td>\n</tr>\n<tr>\n<td>Amylase, Lipase and Acid Phosphatase</td>\n<td>Acute pancreatitis</td>\n</tr>\n<tr>\n<td>Ceruloplasmin</td>\n<td>Hepatolenticular degeneration (Wilson disease)</td>\n</tr>\n<tr>\n<td>&gamma;-Glutamyl transferase</td>\n<td>Liver diseases (Alcoholic Liver Disease)</td>\n</tr>\n<tr>\n<td>&beta;-Glucocerebrosidase</td>\n<td>Gaucher disease</td>\n</tr>\n<tr>\n<td>Alkaline Phosphatase (isozymes)</td>\n<td>Bone disorders, obstructive liver diseases</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0198",
      "difficulty": "medium"
    },
    {
      "text": "You are examining the peripheral smear of a patient with anemia and see the following finding. What is responsible for the underlying change?",
      "choices": [
        {
          "id": 1,
          "text": "Altered cell membrane lipids"
        },
        {
          "id": 2,
          "text": "Abnormal cytoskeleton"
        },
        {
          "id": 3,
          "text": "Nuclear remnant"
        },
        {
          "id": 4,
          "text": "Ribosomal precipitation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given peripheral smear shows <strong>Cabot rings</strong> which are <strong>nuclear remnants.</strong></p>\n<p><strong>Cabot rings</strong></p>\n<p>Cabot rings are&nbsp;<span>circular, blue, threadlike inclusions with dots. They are <strong>nuclear remnants.</strong> They are seen in hemolytic anemia, megaloblastic anemia, and post-splenectomy.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b3774566c561486796e69634e9214bf7x1280x1047.PNG\" alt=\"Explanation Image\"><p>Other options</p>\n<p>Option A: <strong>Acanthocytes</strong> are formed due to <strong>altered cell membrane lipids.</strong></p>\n<p>Option B: <span><strong>Ovalocytes</strong> (elliptocytes) are formed due to <strong>a</strong></span><strong>bnormal cytoskeleton.</strong></p>\n<p>Option D: <strong>Basophilic stippling</strong> is seen due to <strong>ribosomal precipitation.</strong></p><p><strong>Peripheral smear findings</strong></p>\n<div class=\"page\" title=\"Page 198\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Acanthocyte</strong> (spur cell)</p>\n<p><strong>Acanthocyte&nbsp;</strong>or&nbsp;<strong>spur cells&nbsp;</strong>are characterized by only a few spicules of varying size that project from the cell surface at&nbsp;<strong>irregular</strong>&nbsp;intervals.&nbsp;</p>\n<p>Conditions with acanthocytes include</p>\n<ul>\n<li>Parenchymal liver disease</li>\n<li>Abetalipoproteinemia</li>\n<li>Post splenectomy/ hyposplenism.</li>\n</ul>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1a996e755c964cbf97014911a66170d5x720x682.JPEG\" alt=\"Explanation Image\"><p><strong>Degmacytes&nbsp;</strong>or&nbsp;<strong>bite cells&nbsp;</strong>or&nbsp;<strong>blister cells</strong></p>\n<p>Bite cells result from the <strong>removal of Heinz bodies</strong> by macrophages in the spleen. They are seen in <strong>G6PD deficiency</strong> and drug-induced oxidant hemolysis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/582cf8b27ca043f8a5cc480df7d89abax720x515.JPEG\" alt=\"Explanation Image\"><p><strong>Dacrocytes or tear-drop cells</strong></p>\n<p>These are distorted drop-shaped RBCs. They are seen in <strong>myelofibrosis</strong> and <strong>myelophthisic</strong> anemia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9bfae20e671545e5bc375ecc532f1a97x1242x932.JPEG\" alt=\"Explanation Image\"><p><strong>Echinocyte or Burr cells</strong></p>\n<p>They are red cells with short evenly spaced spicules formed due to <strong>altered</strong> cell <strong>membrane lipids.</strong> They are usually <strong>artifacts</strong> but can be seen in uremia, bleeding ulcers, and gastric carcinoma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/03b451c1478440f39623e83890486c6cx750x600.JPEG\" alt=\"Explanation Image\"><p><strong>Schistocytes or helmet cells</strong> are fragmented RBCs that are seen in <strong>microangiopathic hemolytic anemias</strong> and <strong>mechanical valves.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9e9925a2a99848149d1dbbd8251c02b9x750x600.JPEG\" alt=\"Explanation Image\"><p><strong>Target cells</strong></p>\n<p>These RBCs have a target-like appearance and are often hypochromic. This is due to the <strong>increased redundancy</strong> of cell membranes. They are found in <span>liver disease, </span><span>post-splenectomy, </span><span><strong>thalassemia,</strong> hemoglobin C disease</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0142b38e2d984c6084cde61e13cc4419x261x259.JPEG\" alt=\"Explanation Image\"><p><strong>Spherocytes</strong>:</p>\n<p>These are <strong>spherical</strong> RBCS with a dense appearance and <strong>absence</strong> of <strong>central pallor.</strong> They are found in hereditary spherocytosis and autoimmune hemolytic anemia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/78a2fcff416143c7896765c58db930c8x1280x1143.JPEG\" alt=\"Explanation Image\"><p><strong>Sickle cells</strong></p>\n<p>Sickle cells are b<span>ipolar, spiculated forms, pointed at both ends. They are formed due to <strong>aggregation</strong> of <strong>HbS.</strong> They are seen in <strong>sickle cell anemia.</strong></span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f89e37ae8f574f5e86ca447ceba81f67x1280x1151.JPEG\" alt=\"Explanation Image\"><p><strong>Howell-Jolly bodies</strong></p>\n<p>These are <strong>nuclear remnants</strong> within red cells that are usually small, single, discrete, and <strong>basophilic</strong> in appearance. <span>They are seen in hemolytic anemia, <strong>megaloblastic anemia,</strong> and post-splenectomy.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/07c01774063e49ef8ad67a7010ec2cbdx277x273.JPEG\" alt=\"Explanation Image\"><p><strong>Basophilic stippling</strong></p>\n<p><strong>Blue granules </strong>of various sizes are dispersed throughout the cytoplasm of the red cell, they represent<strong> ribosomal precipitates.&nbsp;</strong>They are seen in lead poisoning and thalassemia.</p><img src=\"https://cdn1.dailyrounds.org/uploads/36d413a92ebd4ecd99d08b4a58aa259f.JPEG\" alt=\"Explanation Image\"><p><strong>Pappenheimer bodies</strong></p>\n<p>These are small dense <strong>basophilic</strong> granules. They are seen in <strong>sideroblastic anemia</strong> and <strong>post-splenectomy.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8e32f789df744f87820cc3cf873c6424x961x720.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5dd20a1da2da48098373b8ef984261fa.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0202",
      "difficulty": "medium"
    },
    {
      "text": "A woman was diagnosed to have metastatic lung adenocarcinoma with CK 7 (-), and CK20 (+) IHC marker. Which of the following is the most likely primary site of origin for this metastasis?",
      "choices": [
        {
          "id": 1,
          "text": "Colorectal cancer"
        },
        {
          "id": 2,
          "text": "Renal cell carcinoma"
        },
        {
          "id": 3,
          "text": "Hepatocellular carcinoma"
        },
        {
          "id": 4,
          "text": "Breast carcinoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the given scenario the IHC of the metastatic tumor in the lung showed CK 7 (-), and CK20 (+) which is suggestive of <strong>colorectal carcinoma.</strong></p>\n<p>Cytokeratin profiles of various primary tumors:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>&nbsp;</p>\n<p>CK 7 Positive</p>\n<p>CK20 positive</p>\n</td>\n<td>\n<ul>\n<li>Cholangiocarcinoma</li>\n<li>Ovarian mucinous carcinoma</li>\n<li>Transitional cell carcinoma</li>\n<li>Pancreatic adenocarcinoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>CK 7&nbsp;Positive&nbsp;</strong></p>\n<p><strong>CK 20 negative</strong></p>\n</td>\n<td>\n<ul>\n<li><strong>Breast carcinoma</strong></li>\n<li>Ovarian serous adenocarcinoma</li>\n<li>Thyroid carcinoma</li>\n<li>Lung carcinoma</li>\n<li>Thymoma</li>\n<li>Endometrial carcinoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>CK 7&nbsp;negative</p>\n<p>CK 20&nbsp;Positive</p>\n</td>\n<td>\n<ul>\n<li><strong>Colorectal adenocarcinoma</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>CK 7 negative</strong></p>\n<p><strong>CK 20 negative</strong></p>\n</td>\n<td>\n<ul>\n<li><strong>Hepatocellular carcinoma</strong></li>\n<li><strong>Renal cell carcinoma</strong></li>\n<li>Prostatic adenocarcinoma</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Immunohistochemistry</strong></p>\n<p>Procedure- On a biopsy specimen, antigen-antibody reaction is done and visualized</p>\n<p><strong>Uses</strong></p>\n<ul>\n<li><span><strong>Categorization</strong> of <strong>undifferentiated</strong> malignant <strong>tumors</strong></span></li>\n<li><span><strong>Determination</strong> of site of <strong>origin</strong> of metastatic tumors</span></li>\n<li><span>Detection of molecules that have <strong>prognostic</strong> or therapeutic <strong>significance.</strong> Ex- Breast cancer( ER,PR,HER-2 positivity)</span></li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Cell of origin/tumour</strong></td>\n<td><strong>Marker</strong></td>\n</tr>\n<tr>\n<td>Epithelial origin</td>\n<td>Cytokeratin</td>\n</tr>\n<tr>\n<td>Mesenchymal origin</td>\n<td>Vimentin</td>\n</tr>\n<tr>\n<td>Glial cells</td>\n<td>GFAP/ Glial fibrillary acid protein</td>\n</tr>\n<tr>\n<td>Smooth cells Ex-Leiomyosarcoma</td>\n<td>SMA/ Smooth muscle actin</td>\n</tr>\n<tr>\n<td>Skeletal muscle Ex. Rhabdomyosarcoma</td>\n<td>Desmin, myogenin</td>\n</tr>\n<tr>\n<td>Vascular origin-Angiosarcoma</td>\n<td>CD31, VEGF, Factor VIII</td>\n</tr>\n<tr>\n<td>Neuroendocrine origin-Pheochromocytoma, Neuroblastoma, Medullary carcinoma of the thyroid, Paraganglioma</td>\n<td>Neuron specific enolase(NSE), Chromagranin, Synaptophysin</td>\n</tr>\n<tr>\n<td>GIST/Gastrointestinal stromal tumor</td>\n<td>DOG1, CD34, CD117</td>\n</tr>\n<tr>\n<td>Malignant melanoma</td>\n<td>HMB-45, S-100, Melan A</td>\n</tr>\n<tr>\n<td>Ewings sarcoma</td>\n<td>CD99, MIC2</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0206",
      "difficulty": "medium"
    },
    {
      "text": "Match the following tumor markers with the respective tumors.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Tumor marker</strong></td>\n<td><strong>Tumor</strong></td>\n</tr>\n<tr>\n<td>1. Neuron-specific enolase</td>\n<td>A. Breast cancer</td>\n</tr>\n<tr>\n<td>2. NMP-22</td>\n<td>B. Ovarian cancer</td>\n</tr>\n<tr>\n<td>3. CA-19-9</td>\n<td>C.Pancreatic cancer</td>\n</tr>\n<tr>\n<td>4. CA-15-3</td>\n<td>D. Small cell carcinoma of the lung</td>\n</tr>\n<tr>\n<td> </td>\n<td>E. Bladder cancer</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-E, 2-D, 3-B, 4-A"
        },
        {
          "id": 2,
          "text": "1-D, 2-E, 3-A, 4-B"
        },
        {
          "id": 3,
          "text": "1-E, 2-D, 3-C, 4-B"
        },
        {
          "id": 4,
          "text": "1-D, 2-E, 3-C, 4-A"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The correct match is<strong> 1-D, 2-E, 3-C, 4-A</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Tumor marker</strong></td>\n<td><strong>Tumor</strong></td>\n</tr>\n<tr>\n<td>1. Neuron-specific enolase</td>\n<td>D. Small cell carcinoma of the lung</td>\n</tr>\n<tr>\n<td>2. NMP-22</td>\n<td>E. Bladder cancer</td>\n</tr>\n<tr>\n<td>3. CA-19-9</td>\n<td>C. Pancreatic cancer</td>\n</tr>\n<tr>\n<td>4. CA-15-3</td>\n<td>A. Breast cancer</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Tumor Markers</h3><p><strong>Tumor Markers</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Tumor Markers</strong></p>\n</td>\n<td>\n<p><strong>Tumor Types</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Hormones</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Human chorionic gonadotropin</p>\n</td>\n<td>\n<p>Trophoblastic tumors, nonseminonmatous testicular tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Calcitonin</p>\n</td>\n<td>\n<p>Medullary carcinoma of thyroid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Catecholamine and metabolites</p>\n</td>\n<td>\n<p>Pheochromocytoma and related tumors</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Oncofetal Antigens</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&alpha;-Fetoprotein</p>\n</td>\n<td>\n<p>Liver cell cancer, nonseminonmatous germ-cell tumors of the&nbsp;testis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoembryonic antigen</p>\n</td>\n<td>\n<p>Carcinomas of the colon, lung, stomach, and heart</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostatic acid phosphatase</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neuron-specific enolase</p>\n</td>\n<td>Small-cell cancer of the lung, neuroblastoma</td>\n</tr>\n<tr>\n<td>\n<p>Lactate dehydrogenase (LDH)</p>\n</td>\n<td>Germ-cell tumors, lymphomas, leukemias</td>\n</tr>\n<tr>\n<td>Thymidine kinase</td>\n<td>Leukemias</td>\n</tr>\n<tr>\n<td>Pyruvate kinase</td>\n<td>Renal cell carcinoma</td>\n</tr>\n<tr>\n<td>Placental alkaline phosphatase</td>\n<td>Seminoma</td>\n</tr>\n<tr>\n<td>\n<p><strong>Specific Proteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Immunoglobulins</p>\n</td>\n<td>\n<p>Multiple myeloma and other gammopathies</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prostate-specific antigen and prostate- specific membrane antigen</p>\n</td>\n<td>\n<p>Prostate cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NMP 22</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Mucins and Other Glycoproteins</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-125</p>\n</td>\n<td>\n<p>Ovarian cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA- 19-9</p>\n</td>\n<td>\n<p>Colon cancer, pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>CA-15-3</p>\n</td>\n<td>\n<p>Breast cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cell-Free DNA markers</strong></p>\n</td>\n<td>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, APC, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Colon cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in stool and serum</p>\n</td>\n<td>\n<p>Pancreatic cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53, RAS</em> mutants in sputum and serum</p>\n</td>\n<td>\n<p>Lung cancer</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><em>TP53</em> mutants in urine</p>\n</td>\n<td>\n<p>Bladder cancer</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>NMP: Nuclear matrix protein</p>\n<p>CA: Carbohydrate antigen</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0210",
      "difficulty": "medium"
    },
    {
      "text": "An elderly man presents to the OPD with decreased urine output and facial puffiness. His estimated glomerular filtration rate was 42 mL/min/1.73 sq.m. What is the stage of his chronic kidney disease according to the KDIGO classification?",
      "choices": [
        {
          "id": 1,
          "text": "Stage 3a"
        },
        {
          "id": 2,
          "text": "Stage 4"
        },
        {
          "id": 3,
          "text": "Stage 5"
        },
        {
          "id": 4,
          "text": "Stage 3b"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In the given scenario, a GFR of 42 ml/min/1.73 m² indicates that the patient is in <strong>stage 3b</strong> according to <strong>KDIGO </strong>classification. </p>\n<p>Kidney Disease Improving Global Outcomes <strong>(KDIGO) stages of</strong> chronic kidney disease <strong>(CKD):</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>GFR</strong></td>\n</tr>\n<tr>\n<td>Stage 1</td>\n<td>&gt; 90 ml/min/1.73 m²  </td>\n</tr>\n<tr>\n<td>Stage 2</td>\n<td>60 to 89 ml/min/1.73 m²</td>\n</tr>\n<tr>\n<td>Stage 3a</td>\n<td>45 to 59 ml/min/1.73 m²</td>\n</tr>\n<tr>\n<td>Stage 3b</td>\n<td>30 to 44 ml/min/1.73 m²</td>\n</tr>\n<tr>\n<td>Stage 4</td>\n<td>15 to 29 ml/min/1.73 m²</td>\n</tr>\n<tr>\n<td>Stage 5 (end-stage renal disease)</td>\n<td>&lt; 15 ml/min/1.73 m²</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Renal function tests</strong></p>\n<p><strong>A) GFR</strong></p>\n<p>GFR is the rate in millilitres per minute at which substances in plasma are filtered through the glomerulus. <span>The <strong>normal GFR</strong> for an adult male is <strong>90 to 120 mL/min</strong></span></p>\n<p>The <strong>characteristics</strong> of an <strong>ideal marker</strong> of <strong>GFR</strong> are as follows: </p>\n<ul>\n<li class=\"half_rhythm\">\n<div>It should <strong>appear</strong> endogenously <strong>in</strong> the <strong>plasma</strong> at a constant rate</div>\n</li>\n<li class=\"half_rhythm\">\n<div>It should be <strong>freely filtered</strong> at the glomerulus</div>\n</li>\n<li class=\"half_rhythm\">\n<div>It can be <strong>neither reabsorbed nor secreted</strong> by the renal tubule</div>\n</li>\n<li class=\"half_rhythm\">\n<div>It should <strong>no</strong>t undergo <strong>extrarenal elimination.</strong></div>\n</li>\n</ul>\n<p><strong>Inulin</strong> i<strong>s</strong> the most commonly <strong>used</strong> marker <strong>for</strong> GFR <strong>estimation.</strong></p>\n<p><strong>B) Serum creatinine</strong></p>\n<p>Creatinine is the <strong>by-product</strong> of <strong>creatine phosphate</strong> in muscle. It is eliminated from the body by the kidney.<br /><strong>Normal range:</strong> 0.6 to 1.2 mg/dl</p>\n<p>It is <strong>increased</strong> in </p>\n<ul>\n<li><span class=\"step-2-imppact2 imppact2 usmle-gs-imppact2 step-2-condensed strongImpactHighlight--qLdOc\"><span class=\"step-1-imppact2 usmle-gs-imppact2 step-1-condensed strongImpactHighlight--qLdOc\">Acute or chronic renal failure</span></span></li>\n<li><span class=\"step-1-imppact2 usmle-gs-imppact2 step-1-condensed strongImpactHighlight--qLdOc\"><span class=\"step-2-imppact2 imppact2 usmle-gs-imppact2 step-2-condensed strongImpactHighlight--qLdOc\"><span class=\"nowrap\">↑ Protein</span> intake</span></span></li>\n<li><span class=\"step-1-imppact2 usmle-gs-imppact2 step-1-condensed strongImpactHighlight--qLdOc\"><span class=\"step-2-imppact2 imppact2 usmle-gs-imppact2 step-2-condensed strongImpactHighlight--qLdOc\">High muscle mass</span></span></li>\n</ul>\n<p><span class=\"step-1-imppact2 usmle-gs-imppact2 step-1-condensed strongImpactHighlight--qLdOc\"><span class=\"step-2-imppact2 imppact2 usmle-gs-imppact2 step-2-condensed strongImpactHighlight--qLdOc\">It is <strong>decreased</strong> in </span></span></p>\n<ul>\n<li><span class=\"step-2-imppact2 imppact2 usmle-gs-imppact2 step-2-condensed strongImpactHighlight--qLdOc\">Low muscle mass</span></li>\n<li>Pregnancy</li>\n</ul>\n<h3 id=\"Y28a8e332b894217e472ac7d7e0358557\"><span>C) Blood urea nitrogen</span></h3>\n<p>Urea is produced in the liver as the <strong>end product</strong> of <strong>protein metabolism</strong> and the <strong>urea cycle. </strong><br /><strong>Normal range:</strong> 5 to 20 mg/dl</p>\n<p>Urea is <strong>elevated</strong></p>\n<ul>\n<li>\n<ul>\n<li><span class=\"step-2-imppact2 imppact2 usmle-gs-imppact2 step-2-condensed strongImpactHighlight--qLdOc\"><span class=\"step-1-imppact2 usmle-gs-imppact2 step-1-condensed strongImpactHighlight--qLdOc\">Reduced GFR(Acute/chronic renal failure)</span></span></li>\n<li class=\"condensed-hidden\">High protein diet</li>\n<li class=\"condensed-hidden\">Upper GI bleeding</li>\n<li class=\"condensed-hidden\">Dehydration</li>\n</ul>\n</li>\n</ul>\n<p>Urea is <strong>decreased</strong> in starvation, low-protein diet, and severe liver disease.</p>\n<p>The <strong>ratio</strong> of <strong>BUN</strong> to <strong>creatinine</strong> can be useful to <strong>differentiate pre-renal</strong> from <strong>renal</strong> causes. In <strong>pre-renal</strong> disease, the <strong>ratio</strong> is close to <strong>20:1,</strong> while in <strong>renal</strong> disease, it is closer to <strong>10:1.</strong> However, <strong>Upper GI bleeding</strong> can be associated with a very high BUN to creatinine ratio (sometimes <strong>&gt;30:1).</strong></p>\n<p><strong>D) Uric acid</strong></p>\n<p><span class=\"step-2-imppact2 imppact2 usmle-gs-imppact2 step-2-condensed strongImpactHighlight--qLdOc\"><span class=\"step-1-imppact2 usmle-gs-imppact2 step-1-condensed strongImpactHighlight--qLdOc\">It is a <strong>catabolic metabolite</strong> of <strong>purines.</strong></span></span></p>\n<p>It is <strong>increased</strong> in</p>\n<ul>\n<li>Acute renal failure</li>\n<li>Tumor lysis syndrome</li>\n<li>Lesch-Nyhan syndrome</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0211",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents to OPD with complaints of vesicles and plaques over the trunk. On examination, the vesicles were characteristically arranged in an annular pattern around the lesion. An immunofluorescence study of his lesions revealed the following picture. Which of the following antigens is targeted in this disease?",
      "choices": [
        {
          "id": 1,
          "text": "BP230"
        },
        {
          "id": 2,
          "text": "BP180"
        },
        {
          "id": 3,
          "text": "Dsg 3"
        },
        {
          "id": 4,
          "text": "Dsg 1"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the given clinical scenario, the presence of vesicles is arranged in an annular fashion around the lesions called <span><strong>string‐of‐pearls,</strong> crown of jewels, or cluster of jewels sign with immunofluorescence showing linear pattern is suggestive of <strong>linear IgA disease.</strong> The antigen targetted in this disease is <strong>BP180</strong> aka <strong>BPAG2.</strong></span></p>\n<p><strong>Direct immunofluorescence</strong></p>\n<p><strong>Linear </strong>fluorescence pattern as shown below occurs due to deposits along the dermo-epidermal<strong>&nbsp;junctions</strong> (DEJ). This is seen in the following conditions:</p>\n<ul>\n<li>Due to linear <strong>IgG </strong>deposits in Bullous Pemphigoid, and Epidermolysis bullosa acquisita.</li>\n<li>Due to linear deposits of <strong>IgA</strong> at <strong>DEJ </strong>in<strong> </strong>Linear IgA dermatosis.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/df75990f1b4a43deb37a8cfede1c3715x1280x1186.JPEG\" alt=\"Explanation Image\"><p><strong>Focal granular deposits </strong>of <strong>IgA</strong> at <strong>papillary tips</strong> are seen in Dermatitis herpetiformis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a06777eb373a4ae886ce210c4c4c74c8x352x265.PNG\" alt=\"Explanation Image\"><p>Fish-net appearance on immunofluorescence is seen in&nbsp;<strong>pemphigus vulgaris.</strong>&nbsp;It is&nbsp;due to&nbsp;<strong>anti-desmoglein IgG antibodies&nbsp;</strong>deposited on the&nbsp;<strong>desmosomes (Dsg3, Dsg1), </strong>which are present inter-cellularly.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/318f58211e314ec0826f9e761351139fx720x410.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Vesiculobullous Disorders</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>Clinical Manifestations</strong></td>\n<td><strong>Histology</strong></td>\n<td><strong>Immuno-pathology</strong></td>\n<td><strong>Autoantigens</strong></td>\n</tr>\n<tr>\n<td>Pemphigus vulgaris <strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Flaccid blisters, denuded skin,oro-mucosal lesions</td>\n<td>Acantholytic blister formed in&nbsp;<strong>suprabasal layer</strong> of epidermis&nbsp;</td>\n<td>Cell surface deposits of IgG on keratinocytes- fish net pattern</td>\n<td><strong>Dsg3, Dsg1</strong> in patients with skin involvement</td>\n</tr>\n<tr>\n<td>Pemphigus foliaceus <strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Crusts and shallow erosions on the scalp, central face, upper chest, and back</td>\n<td>Acantholytic blister formed in&nbsp;<strong>superficial layer</strong> of epidermis&nbsp;</td>\n<td>Cell surface deposits of IgG onkeratinocytes</td>\n<td><strong>Dsg1</strong></td>\n</tr>\n<tr>\n<td>Bullous pemphigoid <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Large tense blisters on flexor surfaces and trunk&nbsp;</td>\n<td><strong>Subepidermal </strong>blister with <strong>eosinophil-rich</strong> infiltrate</td>\n<td>Linear band of IgG and/or C3 in epidermal BMZ&nbsp;</td>\n<td><strong>BPAG1, BPAG2</strong></td>\n</tr>\n<tr>\n<td>Dermatitis herpetiformis<strong>&nbsp;</strong> <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Extremely pruritic small papules and vesicles on elbows, knees, buttocks, and posterior neck</td>\n<td><strong>Subepidermal </strong>blister with <strong>neutrophils </strong>in dermal papillae&nbsp;</td>\n<td>Granular deposits of IgA at the tips of dermal papillae</td>\n<td><strong>Epidermal trans-glutaminase</strong></td>\n</tr>\n<tr>\n<td>Linear IgA disease <strong>&nbsp;</strong> <strong>&nbsp;</strong></td>\n<td>Pruritic small papules on extensor surfaces; occasionally larger, arciform blisters&nbsp;</td>\n<td><strong>Subepidermal </strong>blister with <strong>neutrophil</strong>-rich infiltrate&nbsp;</td>\n<td>Linear band of IgA in epidermalBMZ</td>\n<td><strong>BPAG2</strong></td>\n</tr>\n<tr>\n<td><strong>Epidermo-lysis bullosa acquisita</strong></td>\n<td>Tense bullae and erosions&nbsp;</td>\n<td>Subepidermal blister&nbsp;</td>\n<td>IgG and C3 DEJ &ndash; Continous and linear&nbsp;</td>\n<td><strong>Type VII collagen</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;The images below shows clinical pictures of pemphigus patients.</p>\n<ul>\n<li>Image A - oral erosions in a patient with <strong>pemphigus vulgaris</strong></li>\n<li>Image B - heavily clotted and crusted lesions around the mouth in a patient with <strong>paraneoplastic pemphigus</strong></li>\n<li>Image C - skin lesions found on the trunk in a patient with <strong>pemphigus vulgaris</strong></li>\n<li>Image D - skin lesions on the trunk in a patient with <strong>pemphigus foliaceus</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9f91eeb50e144e818c6d6e857996c593x443x358.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Classification of Vesiculobullous Disorders</h3><p><strong>According to Pathology</strong></p>\n<ul>\n<li><strong>Immunobullous disorders/ Primary blistering disease: </strong>occur due to autoimmunity</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Intraepidermal</strong></p>\n</td>\n<td>\n<p><strong>Subepidermal</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus vulgaris</p>\n</td>\n<td>\n<p>Bullous pemphigoid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus foliaceous</p>\n</td>\n<td>Dermatitis herpetiformis</td>\n</tr>\n<tr>\n<td>\n<p>Pemphigus vegetans</p>\n</td>\n<td>Epidermolysis bullous acquisita</td>\n</tr>\n<tr>\n<td>&nbsp;Pemphigus erythematosus</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><strong>Mechanobullous disorders:</strong> Due to defect in the structure of epidermis\n<ul>\n<li>Epidermolysis bullosa</li>\n<li>Bullous ichthyosiform erythroderma</li>\n</ul>\n</li>\n<li><strong>Other disorders</strong>\n<ul>\n<li>Infections - VZV, HSV, Bullous impetigo, SSSS</li>\n<li>Metabolic - Porphyria, Diabetes, Hemodialysis</li>\n<li>Drug eruptions - Fixed drug eruption, Steven Johnson Syndrome, Erythema Multiforme</li>\n</ul>\n</li>\n</ul>\n<p><strong>According to Site</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Intraepidermal</strong></p>\n</td>\n<td>\n<p><strong>Sub-epidermal (Dermo-epidermal)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>1. Subcorneal (granular layer)</strong></p>\n<ul>\n<li>Pemphigus foliaceous &amp; erythematosus</li>\n<li>Staphylococcal scalded skin syndrome</li>\n<li>Miliaria crystalina</li>\n<li>Bullous impetigo</li>\n<li>Friction blister</li>\n<li>Subcorneal pustular dermatosis</li>\n</ul>\n<p><strong>2. Spinous layer</strong></p>\n<ul>\n<li>Eczematous (atopic) dermatitis</li>\n<li>HSV/VZV infection</li>\n<li>Molluscum contagiosum</li>\n<li>Familial benign pemphigus (Hailey-hailey disease)</li>\n</ul>\n<p><strong>3. Suprabasal</strong></p>\n<ul>\n<li>Pemphigus vulgaris</li>\n<li>Darrier&rsquo;s disease</li>\n</ul>\n<p><strong>4. Basal layer</strong></p>\n<ul>\n<li>Erythema multiforme</li>\n<li>Epidermolysis bullosa simplex</li>\n</ul>\n</td>\n<td>\n<p><strong>1. Junctional (at basal lamina)</strong></p>\n<ul>\n<li>Junctional epidermolysis bullosa</li>\n<li>Bullous pemphigoid</li>\n<li>Toxic epidermal necrolysis</li>\n</ul>\n<p><strong>2. Dermolytic (below basal lamina)</strong></p>\n<ul>\n<li>Epidermolysis bullosa acquisita</li>\n<li>Epidermolysis bullosa dystrophicans</li>\n<li>Deep burns</li>\n<li>Porphyria cutanea tarda</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/6b5b4f55512e4a0ca394454593fc9855.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0212",
      "difficulty": "medium"
    },
    {
      "text": "The blood levels of various cardiac biomarkers are measured in a patient following a myocardial infarction. This is represented in the given graph. Which biomarker does the blue curve depict?",
      "choices": [
        {
          "id": 1,
          "text": "Troponin I"
        },
        {
          "id": 2,
          "text": "Creatine kinase"
        },
        {
          "id": 3,
          "text": "Myoglobin"
        },
        {
          "id": 4,
          "text": "LDH"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>blue curve</strong> in the graph represents <strong>myoglobin</strong> as it is the <strong>first marker</strong> to be <strong>elevated</strong> post-myocardial infarction. Myoglobin rises within 1-4 hours, reaches a peak at around 12 hours, and returns back to normal levels at around 24 hours.</p>\n<p><strong>Cardiac biomarkers - </strong></p>\n<p><strong>Troponin T/I:</strong></p>\n<ul>\n<li>These are the proteins that mediate calcium-mediated contraction of the cardiac and skeletal muscles.</li>\n<li>They are<strong> highly specific </strong>for MI.</li>\n<li>Troponins will remain elevated longer than creatine kinase (CK), for <strong>up to 14 days.</strong></li>\n</ul>\n<p><strong>Creatine kinase (CK):</strong></p>\n<ul>\n<li>It is <strong>less sensitive </strong>and<strong> specific </strong>than troponins</li>\n<li>It can be elevated in other conditions such as hypothyroidism, chronic renal failure, and severe exercise. </li>\n</ul>\n<p><strong>Lactate dehydrogenase (LDH):</strong></p>\n<ul>\n<li>Normally, LDH2&gt;LDH1; but, in MI, LDH1&gt;LDH2. This is called <strong>flipping of the LDH ratio</strong>.</li>\n<li>Current recommendations suggest that LDH no longer has a role in the diagnosis of MI.</li>\n</ul>\n<p><strong>Myoglobin:</strong></p>\n<ul>\n<li aria-level=\"1\">One of the earliest enzymes to increase after MI.</li>\n<li aria-level=\"1\">Not specific to cardiac muscle and can be elevated to any form of injury to skeletal muscle.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8c83203da6f446bdb9fbb148eeea0c2cx1280x1171.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Cardiac Biomarkers</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Time to initial elevation</strong></td>\n<td><strong>Mean time to peak elevation</strong></td>\n<td><strong>Time to return to normal range</strong></td>\n</tr>\n<tr>\n<td>Myoglobin</td>\n<td>1- 4 h</td>\n<td>12 h</td>\n<td>24 h</td>\n</tr>\n<tr>\n<td>CK-MB</td>\n<td>4-8 h</td>\n<td>24 h</td>\n<td>48-72 h</td>\n</tr>\n<tr>\n<td>cTnI</td>\n<td>3-12 h</td>\n<td>24 h</td>\n<td>7-10 d</td>\n</tr>\n<tr>\n<td>cTnT</td>\n<td>3-12 h</td>\n<td>12h &ndash; 2d</td>\n<td>7-10 d&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>CK-MB: Creatine kinase-MB; CTnI: Cardiac-specific troponin I; CTnT: Cardiac-specific troponin T&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/af5c41b3daaa4572985768e9c8081561x1280x1144.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/6d582c56a1b2482e9ad223f73ec2d6cd.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0213",
      "difficulty": "medium"
    },
    {
      "text": "Match the following RBC indices with the corresponding conditions.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>RBC indices</strong></td>\n<td><strong>Condition</strong></td>\n</tr>\n<tr>\n<td>1. Normal MCV, MCH, MCHC, RDW</td>\n<td>A. Thalassemia</td>\n</tr>\n<tr>\n<td>2. Increased MCV, MCH, RDW, and normal MCHC</td>\n<td>B. Iron deficiency anemia</td>\n</tr>\n<tr>\n<td>3. Decreased MCV, MCH, MCHC and increased RDW</td>\n<td>C. Acute blood loss</td>\n</tr>\n<tr>\n<td>4. Decreased MCV, MCH, MCHC and normal RDW</td>\n<td>D. Megaloblastic anemia</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-D, 2-C, 3-A, 4-B"
        },
        {
          "id": 2,
          "text": "1-C, 2-D, 3-A, 4-B"
        },
        {
          "id": 3,
          "text": "1-C, 2-D, 3-B, 4-A"
        },
        {
          "id": 4,
          "text": "1-D, 2-C, 3-B, 4-A"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The correct match is 1-C, 2-D, 3-B, 4-A</p>\n<table>\n<tbody>\n<tr>\n<td><strong>RBC indices</strong></td>\n<td><strong>Condition</strong></td>\n</tr>\n<tr>\n<td>1. Normal MCV, MCH, MCHC, RDW</td>\n<td>C. Acute blood loss</td>\n</tr>\n<tr>\n<td>2. Increased MCV, MCH, RDW, and normal MCHC</td>\n<td>D. Megaloblastic anemia</td>\n</tr>\n<tr>\n<td>3. Decreased MCV, MCH, MCHC and increased RDW</td>\n<td>B. Iron deficiency anemia</td>\n</tr>\n<tr>\n<td>4. Decreased MCV, MCH, MCHC and normal RDW</td>\n<td>A. Thalassemia</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>RBC indices</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>RBC indices</strong></td>\n<td><strong>Definition</strong></td>\n<td><strong>Normal range</strong></td>\n<td><strong>Significance</strong></td>\n</tr>\n<tr>\n<td><strong>Mean corpuscular volume (MCV)</strong></td>\n<td>MCV defines the <strong>size</strong> of the red blood cells. It is given by the formula<strong>&nbsp;PCV/RBC</strong> (fL).</td>\n<td>80-97 fL</td>\n<td>\n<p><strong>Increased:</strong> Macrocytic anemia<strong>(Megaloblastic anemia)</strong>&nbsp;</p>\n<p><strong>Decreased:</strong> Microcytic anemia <strong>(Iron deficiency anemia, thalassemia)</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Mean corpuscular hemoglobin (MCH)</strong></td>\n<td>MCH quantifies the amount of <strong>hemoglobin per red blood cell.</strong>&nbsp;It is given by the formula <strong>hemoglobin/RBC</strong> (pg).</td>\n<td>27-31 pg</td>\n<td>\n<p><strong>Increased:</strong> Macrocytic anemia</p>\n<p><strong>Decreased:</strong> Microcytic anemia</p>\n</td>\n</tr>\n<tr>\n<td><strong>Mean corpuscular hemoglobin concentration (MCHC)</strong></td>\n<td>MCHC indicates the amount of hemoglobin per unit volume. It is given by the formula <strong>hemoglobin/PCV&nbsp;</strong>(g/dL).</td>\n<td>32-36 g/dl</td>\n<td>\n<p><strong>Increased:</strong> Hereditary spherocytosis</p>\n<p><strong>Decreased:</strong> Microcytic anemia</p>\n</td>\n</tr>\n<tr>\n<td><strong>Red cell distribution width (RDW</strong>)</td>\n<td>RDW represents the coefficient of variation of the red blood cell volume distribution (size) and is expressed as a percentage.</td>\n<td>11.5-14.5%</td>\n<td>\n<p><strong>Increased:</strong> Iron deficiency anemia, Megaloblastic anemia</p>\n<p><strong>Normal:</strong> Thalassemia</p>\n&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span>Note: In anemia due to <strong>acute blood loss</strong> and <strong>hemolytic anemias,</strong> MCV, MCH, and MCHC are all within <strong>normal</strong> limits.</span><span>&nbsp;</span></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Parameter</strong></td>\n<td><strong>Normal range</strong></td>\n<td><strong>Increased</strong></td>\n<td><strong>Decreased</strong></td>\n</tr>\n<tr>\n<td><strong>RBC count</strong></td>\n<td>\n<ul>\n<li><span><strong>Males</strong>: 4.3-5.9 million/mm<sup>3</sup></span></li>\n<li><span><strong>Females:</strong> 3.5-5.5 million/mm<sup>3</sup></span></li>\n</ul>\n</td>\n<td>Polycythemia</td>\n<td>Anemia</td>\n</tr>\n<tr>\n<td><strong>Hemoglobin</strong></td>\n<td>\n<ul>\n<li><span><strong>Males:</strong> 13.5-17.5 g/dL</span></li>\n<li><strong><span>Females</span>:</strong> 12.0-16.0 g/dL</li>\n</ul>\n<div class=\"page\" title=\"Page 189\">\n<div class=\"layoutArea\">&nbsp;</div>\n</div>\n</td>\n<td>Polycythemia</td>\n<td>Anemia</td>\n</tr>\n<tr>\n<td><strong>Hematocrit(PCV): </strong>PCV is defined as the ratio of the volume of RBCs to that of whole blood and is expressed as a percentage.</td>\n<td>\n<ul>\n<li><strong><span>Males</span>:</strong> 41%-53%</li>\n<li><strong><span>Females</span>:</strong> 36%-46%</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Polycythaemia</li>\n<li>Dehydration due to severe vomiting, diarrhea, profuse sweating</li>\n<li>Burns</li>\n<li>Shock</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Anemia</li>\n<li>Pregnancy</li>\n</ul>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Reticulocyte count</strong></td>\n<td>\n<ul>\n<li><strong>Infants:</strong> <span>2-6%</span></li>\n<li><strong>Adult</strong> and <strong>children:</strong> <span>0.5 - 2.5%</span></li>\n</ul>\n</td>\n<td>\n<ul>\n<li>After haemorrhage</li>\n<li>Haemolysis</li>\n<li>Hematopoietic response of anemia to treatment</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Ineffective erythropoiesis</li>\n<li>Aplastic anemia</li>\n<li>Thalassemia</li>\n<li>Myelosclerosis</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"page\" title=\"Page 193\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 189\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 208\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 196\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 196\">\n<div class=\"section\">\n<div class=\"layoutArea\">&nbsp;</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0220",
      "difficulty": "easy"
    },
    {
      "text": "During ward rounds, you come across the ECG of a patient, which is given below. Which of the following can cause the given ECG change?",
      "choices": [
        {
          "id": 1,
          "text": "Metabolic alkalosis"
        },
        {
          "id": 2,
          "text": "Primary adrenal insufficiency"
        },
        {
          "id": 3,
          "text": "Cushing's syndrome"
        },
        {
          "id": 4,
          "text": "Magnesium deficiency"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given ECG shows <strong>tall,</strong> peaked <strong>T</strong> <strong>waves</strong> and <strong>loss</strong> of <strong>P waves,</strong> indicating that the patient is suffering from <strong>hyperkalemia. Primary adrenal insufficiency</strong> can result in hyperkalemia. <strong>Metabolic alkalosis, Cushing's syndrome,</strong> and <strong>magnesium deficiency</strong> cause <strong>hypokalemia.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Electrolyte abnormality</strong></td>\n<td><strong>Definition</strong></td>\n<td><strong>Conditions associated</strong></td>\n<td><strong>ECG changes</strong></td>\n</tr>\n<tr>\n<td><strong>Hyperkalemia</strong></td>\n<td>Plasma K+ concentration of &gt; 5.5 mM</td>\n<td>\n<p><strong>Pseudohyperkalemia</strong></p>\n<p>Cellular efflux: Thrombocytosis, leukocytosis, erythrocytosis</p>\n<p><strong>Extracellular shift</strong></p>\n<ul>\n<li>Metabolic acidosis</li>\n<li>Beta2 antagonists</li>\n<li>Rapid tumor lysis</li>\n</ul>\n<p><strong>Inadequate excretion</strong></p>\n<p>Inhibition of renin-angiotensin-aldosterone axis</p>\n<ul>\n<li>ACE inhibitors: Captopril, Enalapril</li>\n<li>ARB's: Losartan, Telmisartan</li>\n<li>Renin-inhibitors: Aliskiren</li>\n<li>Mineralocorticoid receptor antagonist: Spironolactone</li>\n<li>Epithelial sodium channel blockade: Amiloride</li>\n<li>Advanced renal insufficiency</li>\n</ul>\n<p><strong>Primary adrenal insufficiency</strong></p>\n<p><strong>Congestive cardiac failure</strong></p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 670\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Tall peaked T-waves</li>\n<li>Flat P waves</li>\n<li>Widened QRS complex </li>\n<li>Sine wave</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Hypokalemia</strong></td>\n<td>\n<div class=\"page\" title=\"Page 389\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Plasma K+ concentration of &lt;3.5 mM</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p><strong>Decreased intake</strong>: Starvation</p>\n<p><strong>Redistribution into cells</strong></p>\n<ul>\n<li><strong>Metabolic alkalosis</strong></li>\n<li>Insulin</li>\n<li>Beta 2 agonists</li>\n<li>Increased β2-adrenergic sympathetic activity: postmyocardial infarction, head injury</li>\n<li>Total parenteral nutrition </li>\n</ul>\n<p><strong>Increased losses</strong></p>\n<ul>\n<li>Diarrhea</li>\n<li>Sweating</li>\n<li>Diuretics</li>\n<li>Mineralocorticoid excess: Ex <strong>Cushing's syndrome,</strong> Primary hyperaldosteronism</li>\n<li><strong>Magnesium deficiency</strong></li>\n</ul>\n</td>\n<td>\n<div class=\"page\" title=\"Page 670\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>ST depression</li>\n<li>Flat T-wave</li>\n<li>QT prolongation</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Hypernatremia</strong></td>\n<td>Plasma Na+ concentrations &gt; 145 mM</td>\n<td>\n<ul>\n<li>Diabetes insipidus</li>\n<li>Vomiting</li>\n<li>Diarrhea</li>\n<li>Burns</li>\n<li>Excessive sweating</li>\n</ul>\n</td>\n<td> </td>\n</tr>\n<tr>\n<td><strong>Hyponatremia</strong></td>\n<td>Plasma Na+ concentrations of &lt; 135 mM</td>\n<td>\n<p><strong>Hypovolemic Hyponatremia</strong></p>\n<div class=\"page\" title=\"Page 383\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Diuretic excess</li>\n<li>Mineral corticoid deficiency</li>\n<li>Salt-losing deficiency</li>\n<li>Vomiting</li>\n<li>Diarrhea</li>\n<li>Third spacing of fluids</li>\n<li>Burns</li>\n<li>Pancreatitis</li>\n<li>Trauma</li>\n</ul>\n<div class=\"page\" title=\"Page 383\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\"> <strong><span>Euvolemic hyponatremia</span></strong></div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 383\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Glucocorticoid deficiency</li>\n<li>Hypothyroidism</li>\n<li>Stress</li>\n<li>Drugs</li>\n<li>SIADH</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Hypervolemic hyponatremia</strong></p>\n<div class=\"page\" title=\"Page 383\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Acute or chronic renal failure</li>\n<li>Nephrotic syndrome</li>\n<li>Cirrhosis</li>\n<li>Cardiac failure </li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td> </td>\n</tr>\n<tr>\n<td><strong>Hypercalcemia</strong></td>\n<td>Serum calcium &gt;10.5 mg/dl</td>\n<td>\n<div class=\"page\" title=\"Page 397\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Excessive PTH production</strong></p>\n<p><strong>Hypercalcemia of malignancy</strong></p>\n<ul>\n<li>Overproduction of PTHrP</li>\n<li>Lytic skeletal metastases( Breast, myeloma)</li>\n</ul>\n<p><strong>Excessive Vitamin D production:</strong></p>\n<div class=\"page\" title=\"Page 397\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Granulomatous diseases (sarcoidosis, tuberculosis, silicosis)</li>\n<li>Lymphoma</li>\n<li>Vitamin D intoxication</li>\n</ul>\n<p><strong>Excessive calcium intake</strong></p>\n<ul>\n<li>Milk-alkali syndrome</li>\n<li>Total parenteral nutrition</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Increased in bone resorption:</strong></p>\n<ul>\n<li>Hyperthyroidism</li>\n<li>Immobilization</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 670\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 398\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Atrioventricular (AV) block</li>\n<li>Short QT interval</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Hypocalcemia</strong></td>\n<td>Serum calcium &lt; 8.8 mg/dL</td>\n<td>\n<p><strong>Low PTH levels</strong></p>\n<ul>\n<li>Parathyroid agenesis: Di-George syndrome</li>\n<li>Parathyroid destruction: Surgical, Radiation</li>\n<li>Reduced parathyroid function: Hypomagnesemia</li>\n</ul>\n<p><strong>High PTH levels</strong></p>\n<ul>\n<li>Vitamin D deficiency</li>\n<li>Parathyroid hormone resistance syndromes</li>\n<li>Drugs: Calcium chelators </li>\n</ul>\n</td>\n<td>\n<div class=\"page\" title=\"Page 670\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Prolonged QT intervals</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/6e6f29c84fa845528832209bb8078442.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0224",
      "difficulty": "medium"
    },
    {
      "text": "A pathologist is studying the factors affecting ESR. All of the following can cause an increase in ESR except",
      "choices": [
        {
          "id": 1,
          "text": "Polycythemia"
        },
        {
          "id": 2,
          "text": "Pregnancy"
        },
        {
          "id": 3,
          "text": "Hyperfibrinogenaemia"
        },
        {
          "id": 4,
          "text": "Hypoalbuminemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Polycythemia </strong>decreases ESR.</p>\n<p><strong>Inflammatory markers:</strong></p>\n<p><strong>1) Erythrocyte sedimentation rate (ESR)</strong></p>\n<p>a) Factors affecting ESR</p>\n<div class=\"page\" title=\"Page 204\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><strong>Rouleaux</strong> formation: An increase in rouleaux formation increases ER</li>\n<li>Concentration of <strong>fibrinogen</strong> in plasma: An increase in fibrinogen increases ESR <strong>(Option</strong> <strong>C</strong>)</li>\n<li>Concentration of α and β globulins: An increase in <strong>albumin</strong> decreases ESR( <strong>Option</strong> <strong>D</strong>)</li>\n<li><strong>Length</strong> of the <strong>tube:</strong> Longer tube decreases ESR</li>\n<li>The ratio of red cells to <strong>plasma:</strong> An Increase in plasma increases ESR</li>\n<li><strong>Bore</strong> of the tube: If the bore of the tube is more ESR is more</li>\n<li>Position of the tube</li>\n</ul>\n<div class=\"page\" title=\"Page 204\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>b) Phases in ESR</p>\n<ul>\n<li>Phase of <strong>Rouleaux</strong> formation: In the initial period of 10 minutes, rouleaux formation occurs with little sedimentation.</li>\n<li>Phase of <strong>settling:</strong> In the next 40 minutes, RBCs settle at a constant rate</li>\n<li>Phase of <strong>packing:</strong> In the last 10 minutes packing of the RBCs to the bottom occurs.</li>\n</ul>\n<div class=\"page\" title=\"Page 205\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>c) Methods of ESR estimation</p>\n<ul>\n<li>Westergren’smethod</li>\n<li>Wintrobe’smethod</li>\n<li>Micro ESR method</li>\n<li>Automated method</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 206\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Diseases causing raised ESR</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><strong>Diseases causing low ESR</strong></td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 206\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Tuberculosis</li>\n<li>Subacute bacterial endocarditis</li>\n<li>Acute myocardial infarction</li>\n<li>Rheumatoid arthritis</li>\n<li>Shock</li>\n<li>Anemias</li>\n<li>Liver disease</li>\n<li><span>Multiple myeloma</span></li>\n<li><strong>Pregnancy</strong></li>\n<li>Ankylosing spondylitis</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 206\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><strong>Polycythaemia</strong></li>\n<li>Spherocytosis</li>\n<li>Sickle cell anemia</li>\n<li>Congestive heart failure</li>\n<li>Newborn infant</li>\n<li>Hypofibrinogenaemia</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>2) C-reactive protein</strong></p>\n<p>CRP is an <strong>acute-phase reactant</strong> protein <strong>synthesized</strong> in the <strong>liver.</strong>  <strong>IL-6</strong> helps in the <strong>production</strong> of CRP. It <span>has both proinflammatory and anti-inflammatory properties. </span>The levels of CRP rise and fall rapidly with the onset and removal of the inflammatory stimulus, respectively. Persistently elevated CRP levels can be seen in chronic inflammatory conditions </p>\n<p>a) Interpretation of CRP levels:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Values</strong></td>\n<td><strong>Interpretation</strong></td>\n</tr>\n<tr>\n<td>\n<p><strong>&lt; 0.3 mg/dL</strong></p>\n</td>\n<td>\n<p><strong>Norma</strong>l</p>\n</td>\n</tr>\n<tr>\n<td>0.3 to 1 mg/dL</td>\n<td>Normal or <strong>minor elevation</strong> (can be seen in obesity, pregnancy, depression, diabetes, common cold, gingivitis, periodontitis, sedentary lifestyle, cigarette smoking, and genetic polymorphisms).</td>\n</tr>\n<tr>\n<td>1 to 10 mg/dL</td>\n<td><strong>Moderate elevation</strong> (Systemic inflammation such as RA, SLE, or other autoimmune diseases, malignancies, myocardial infarction, pancreatitis, bronchitis).</td>\n</tr>\n<tr>\n<td>&gt; 10 mg/dL</td>\n<td><strong>Marked elevation</strong> (Acute bacterial infections, viral infections, systemic vasculitis, major trauma).</td>\n</tr>\n<tr>\n<td><strong>&gt; 50 mg/dL</strong></td>\n<td>\n<p><strong>Severe elevation</strong> (Acute bacterial infections).</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0228",
      "difficulty": "hard"
    },
    {
      "text": "A 35-year-old female patient with a history of recurrent episodes of numbness, weakness, and visual disturbances is suspected to have multiple sclerosis. All of the following can be seen in CSF analysis in Multiple sclerosis except",
      "choices": [
        {
          "id": 1,
          "text": "Normal glucose concentration"
        },
        {
          "id": 2,
          "text": "Elevated IgG index"
        },
        {
          "id": 3,
          "text": "Albuminocytologic dissociation"
        },
        {
          "id": 4,
          "text": "Oligoclonal bands"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Albuminocytologic dissociation</strong> is not seen on CSF analysis of a patient with multiple sclerosis. <strong>Albuminocytologic dissociation</strong> is seen in <strong>Guillian-Barr&eacute; syndrome.</strong></p>\n<p><strong>CSF analysis in acute demyelinating diseases</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td><strong>CSF findings</strong></td>\n</tr>\n<tr>\n<td><strong>Transverse myelitis</strong></td>\n<td>\n<ul>\n<li>Pleocytosis</li>\n<li>Elevated protein concentration</li>\n<li>Oligoclonal bands</li>\n<li>Elevated IgG index (increased CSF IgG compared to serum IgG levels)</li>\n<li>Elevated CSF IL-6</li>\n<li>\n<div>CSF sugar, pressure is usually normal.</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Multiple sclerosis</strong></td>\n<td>\n<ul>\n<li>Pleocytosis (5&ndash;50 cells / cu mm; lymphocytes)</li>\n<li>Elevated protein</li>\n<li><strong>Oligoclonal Bands</strong> may be present (Highly diagnostic)</li>\n<li><strong>Elevated IgG index</strong>&nbsp;</li>\n<li><strong>Normal glucose</strong> concentration</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Guillain Barrie syndrome</strong></td>\n<td>\n<ul>\n<li>Normal CSF cell count.</li>\n<li>Elevated CSF protein levels</li>\n<li><strong>Cyto-albuminergic dissociation</strong></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>CSF analysis</strong></p>\n<p>CSF is <strong>ultra-filtrate</strong> of plasma. It is continuously <strong>secreted</strong> by the <strong>choroid plexus</strong>&nbsp;inside the ventricles of the brain and <strong>circulates</strong> in the <strong>subarachnoid space</strong> of the brain and spinal cord through CSF pathways.</p>\n<p>The main function of the CSF is to <strong>reduce</strong> the <strong>buoyancy</strong> of the brain. It also supplies <strong>nutrition</strong> and also helps in the <strong>removal</strong> of various <strong>substances</strong> like amino acids, neurotransmitters, metabolic byproducts, and cells.</p>\n<p><strong>CSF findings in different types of meningitis:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>Parameter/ Meningitis</td>\n<td><strong>Normal</strong></td>\n<td><strong>Bacterial&nbsp;</strong></td>\n<td><strong>Tubercular&nbsp;</strong></td>\n<td><strong>Viral&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>CSF pressure </strong></td>\n<td>50&ndash;200 mm H<sub>2</sub>O</td>\n<td>Raised</td>\n<td>Raised</td>\n<td>Raised</td>\n</tr>\n<tr>\n<td>\n<p><strong>Appear</strong><strong>ance</strong></p>\n</td>\n<td>Clear</td>\n<td>Turbid</td>\n<td>\n<p>Clear (cob-</p>\n<p>web formation)</p>\n</td>\n<td>Clear</td>\n</tr>\n<tr>\n<td><strong>Glucose</strong></td>\n<td>50&ndash;80 mg/dL (two-thirds of blood glucose)</td>\n<td>Decreased</td>\n<td>Decreased</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td><strong>Protein</strong></td>\n<td>15-40 mg/dl</td>\n<td>&gt;100 mg/dl</td>\n<td>100-200 mg/dl</td>\n<td>20-80 mg/dl</td>\n</tr>\n<tr>\n<td>\n<p><strong>Predomin</strong><strong>ant c</strong><strong>ells</strong></p>\n</td>\n<td>\n<p>Lymphocytes</p>\n<p>(0-5/&mu;L)</p>\n</td>\n<td>\n<p>Neutrophils</p>\n<p>(&gt;1000/&mu;L)</p>\n</td>\n<td>\n<p>Lymphocytes</p>\n<p>(25-100/&mu;L)</p>\n</td>\n<td>\n<p>Lymphocytes</p>\n<p>(25-100/&mu;L)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>In parasitic meningitis, CSF pressure is normal, and WBC count is 150-200&mu;L/L with predominant cells of eosinophils. The glucose level is normal. Protein is expected to be seen in the range of 15-200mg/dl.</p>\n<p><strong>CSF findings in Sub-arachnoid hemorrhage (SAH)</strong></p>\n<p>The presence of RBCs (More than 1000 cells/ cu mm) or <strong>xanthochromia</strong> confirms the diagnosis of SAH.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0231",
      "difficulty": "medium"
    },
    {
      "text": "Urine analysis of a patient reveals fixed specific gravity at 1.010. All of the following can be considered as differential diagnosis except",
      "choices": [
        {
          "id": 1,
          "text": "Chronic kidney disease"
        },
        {
          "id": 2,
          "text": "Sickle cell nephropathy"
        },
        {
          "id": 3,
          "text": "ADH deficiency"
        },
        {
          "id": 4,
          "text": "Dehydration"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The specific gravity of urine <strong>fixed</strong> at <strong>1.010</strong> is suggestive of <strong>isothenuria.</strong> Isothenuria is the impaired ability to concentrate urine. Dehydration does not lead to isothenuria. It causes an <strong>increase</strong> in <strong>specific gravity.</strong></p>\n<p><strong>Urine analysis</strong></p>\n<p>Physical examination&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Parameter</strong></td>\n<td><strong>Normal&nbsp;</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Volume</strong></td>\n<td>700-2500 ml/ day</td>\n<td>\n<p><strong>Polyuria</strong>- Passage of &gt;2500 ml of urine in 24 hours.</p>\n<p><strong>Causes</strong></p>\n<ul>\n<li>Increased water intake</li>\n<li>Diabetes mellitus</li>\n<li>Diabetes insipidus</li>\n</ul>\n<p><strong>Oliguria</strong>- Passage of &lt; 500 ml of urine in 24 hours</p>\n<p><strong>Causes</strong></p>\n<ul>\n<li>Decreased water intake</li>\n<li>Dehydration</li>\n<li>Renal ischemia</li>\n</ul>\n<p><strong>Anuria</strong>- Passage of &lt;150 ml of urine in 24 hours</p>\n<p><strong>Causes</strong></p>\n<div class=\"page\" title=\"Page 27\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Renal stones</li>\n<li>Renal tumors</li>\n<li>Renal ischemia</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Color</strong></td>\n<td>Clear/Pale/Straw colored due to urochrome</td>\n<td>\n<ul>\n<li><strong>Colorless:</strong> Diabetes Mellitus, Diabetes insipidus, Excessive water intake</li>\n<li><strong>Orange</strong> color: I<span>ncreased urobilinogen, concentrated urine.</span></li>\n<li><strong>Smoky</strong> urine: S<span>mall amount of blood, administration of vitamin B12</span></li>\n<li><strong>Red</strong> color: <span>haematuria, hemoglobinuria</span></li>\n<li><strong>Brown</strong> color: Bile</li>\n<li><strong>Milky:</strong> Pus, Fat</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Odor</strong></td>\n<td>Faint aromatic odor</td>\n<td>\n<ul>\n<li><strong>Pungent</strong> odor: due to ammonia produced by bacteria</li>\n<li><strong>Putrid</strong> odor: Urinary tract infection</li>\n<li><strong>Fruity</strong> odor: Ketoacidosis</li>\n<li><strong>Mousy</strong> odor: Phenylketonuria</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>pH</strong></td>\n<td>Slightly acidic (4.5-7.0)</td>\n<td>\n<p><strong>Acidic</strong> urine:</p>\n<div class=\"page\" title=\"Page 28\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>High protein intake</li>\n<li>Ingestion of acidic fruits.</li>\n<li>Respiratory and metabolic acidosis</li>\n<li>UTI by E. coli</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<p><strong>Alkaline</strong> urine:</p>\n<div class=\"page\" title=\"Page 28\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Citrus fruits</li>\n<li>Respiratory and metabolic alkalosis</li>\n<li>UTI by Proteus, Pseudomonas</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Specific gravity</strong></td>\n<td>\n<div class=\"page\" title=\"Page 29\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>1.003 to 1.030</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p><strong>Low</strong> specific gravity</p>\n<div class=\"page\" title=\"Page 29\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Excess water intake</li>\n<li>Diabetes insipidus</li>\n</ul>\n</div>\n</div>\n</div>\n<p><strong>High</strong> specific gravity</p>\n<div class=\"page\" title=\"Page 29\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Dehydration</li>\n<li>Albuminuria</li>\n<li>Glycosuria</li>\n</ul>\n</div>\n</div>\n</div>\n<p><strong>Fixed</strong> specific gravity/Isothenuria <strong>(1.010)</strong></p>\n<div class=\"page\" title=\"Page 29\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><strong>ADH deficiency</strong></li>\n<li><strong>Chronic kidney disease</strong></li>\n<li><strong>Sickle cell nephropathy</strong></li>\n</ul>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Microscopic Appearance of Various Stones</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/15e48f770c514c65b97b1eefea14db50x1280x2927.JPEG\" alt=\"Pearl Image\"><p>Xanthine, indinavir, and triamterene stones are <strong>radiolucent</strong>.</p><hr><h3>Related Pearl: Urinary Casts and Their Significance</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8ce4f74ab9824f42b8cb05ac3433314cx1280x3456.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0209",
      "difficulty": "medium"
    },
    {
      "text": "You are an intern posted in the labor ward. You see the results of the biophysical profile done in a pregnant woman at her 36th week of gestation. Her biophysical profile score is 8 with reduced amniotic fluid volume. How would you manage this case?",
      "choices": [
        {
          "id": 1,
          "text": "Repeat testing the next day"
        },
        {
          "id": 2,
          "text": "Repeat testing at weekly interval "
        },
        {
          "id": 3,
          "text": "Administration single dose of steroids and deliver"
        },
        {
          "id": 4,
          "text": "Immediate delivery"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><span>A Manning score of 8 with reduced amniotic fluid volume in a woman ≥ 36 weeks is managed with <strong>immediate delivery.</strong></span></p>\n<p><span>Interpretation and management of BPP scores:</span></p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>BPP score</strong></span></td>\n<td><span><strong>Interpretation</strong></span></td>\n<td><span><strong>Management</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>10</strong></span></td>\n<td><span>Normal, nonasphyxiated fetus</span></td>\n<td><span>Repeat test weekly </span></td>\n</tr>\n<tr>\n<td><span><strong>8</strong> <strong>with normal AFV</strong></span></td>\n<td><span>Normal, nonasphyxiated fetus</span></td>\n<td><span>Repeat test weekly</span></td>\n</tr>\n<tr>\n<td><span><strong>8 with decreased AFV</strong></span></td>\n<td><span>Suspicion of chronic fetal asphyxia</span></td>\n<td>\n<div class=\"page\" title=\"Page 405\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span>If ≥36 weeks, delivery is done</span></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><span><strong>6</strong></span></td>\n<td><span>Possible fetal asphyxia</span></td>\n<td>\n<p><span>If AFV is abnormal-Deliver&gt;36 weeks.</span></p>\n<p><span>If AFV is normal- deliver≥ 37 weeks. </span></p>\n</td>\n</tr>\n<tr>\n<td><span><strong>4</strong></span></td>\n<td><span>Probable fetal asphyxia</span></td>\n<td>\n<div class=\"page\" title=\"Page 405\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span>If ≥32 weeks, deliver</span></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><span><strong>0-2</strong></span></td>\n<td><span>Almost certain fetal asphyxia</span></td>\n<td><span>Delivery </span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span><strong>Antenatal profile</strong></span></p>\n<p><span><strong>Maternal investigations </strong></span></p>\n<p><span><strong>a) Routine investigations</strong></span></p>\n<div class=\"page\" title=\"Page 132\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><span><strong>Blood investigation:</strong> Hemoglobin, hematocrit, ABO, Rh-grouping, blood glucose, and VDRL.</span></li>\n<li><span><strong>Urine analysis</strong>: Protein, sugar, and pus cells. If significant proteinuria is found, a “clean catch” specimen of midstream urine is collected for culture and sensitivity test.</span></li>\n<li><span><strong>Cervical cytology</strong> study by Papanicolaou stain</span></li>\n</ul>\n<div class=\"page\" title=\"Page 132\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>b) Special investigations:</strong></span></p>\n<ul>\n<li><span><strong>Serological</strong> tests: Rubella, hepatitis B virus, and HIV.</span></li>\n<li><span><strong>Genetic</strong> screening:</span></li>\n</ul>\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<table>\n<tbody>\n<tr>\n<td><span><strong>Dual test (1<sup>st</sup> trimester)</strong></span></td>\n<td><span><strong>Triple test (2<sup>nd</sup> trimester)</strong></span></td>\n<td><span><strong>Quadruple test (2<sup>nd</sup> trimester)</strong></span></td>\n</tr>\n<tr>\n<td><span>Beta HCG </span></td>\n<td><span>Beta HCG </span></td>\n<td><span>Beta HCG </span></td>\n</tr>\n<tr>\n<td><span>PAPP-A </span></td>\n<td><span>Unconjugated estriol </span></td>\n<td><span>Unconjugated estriol </span></td>\n</tr>\n<tr>\n<td rowspan=\"2\"><span> </span></td>\n<td><span>MSAFP </span></td>\n<td><span>MSAFP </span></td>\n</tr>\n<tr>\n<td><span> </span></td>\n<td><span>Serum inhibin A</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Parameter</strong></span></td>\n<td><span><strong>Trisomy 21</strong></span></td>\n<td><span><strong>Trisomy 18</strong></span></td>\n<td><span><strong>Neural tube defect or abdominal wall defect</strong> </span></td>\n</tr>\n<tr>\n<td><span><strong>MSAFP</strong></span></td>\n<td><span>Low</span></td>\n<td><span>Low</span></td>\n<td><span>High</span></td>\n</tr>\n<tr>\n<td><span><strong>β hCG</strong></span></td>\n<td><span>High</span></td>\n<td><span>Low</span></td>\n<td><span>Normal</span></td>\n</tr>\n<tr>\n<td><span><strong>Unconjugated estriol</strong></span></td>\n<td><span>Low</span></td>\n<td><span>Low</span></td>\n<td><span>Normal</span></td>\n</tr>\n<tr>\n<td><span><strong>Inhibin A</strong></span></td>\n<td><span>High</span></td>\n<td><span>Normal/Low</span></td>\n<td><span>Normal</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"page\" title=\"Page 133\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>c) Ultrasound examination:</strong></span></p>\n<p><span>A <strong>dating scan</strong> is performed in the <strong>first trimester:</strong></span></p>\n<ul>\n<li><span>Accurate dating</span></li>\n<li><span>Number of fetuses</span></li>\n<li><span>Gross fetal anomalies</span></li>\n<li><span>Uterine or adnexal pathology</span></li>\n</ul>\n<p><span><strong>Booking/Anomaly</strong> scan <strong>(18–20 weeks)</strong></span></p>\n<ul>\n<li><span>Detailed fetal anatomy survey to detect any structural abnormality</span></li>\n<li><span>Placental localization.</span></li>\n</ul>\n<div class=\"page\" title=\"Page 133\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>d) Repetition of the investigations: </strong></span></p>\n<ul>\n<li><span><strong>Hemoglobin</strong> estimation is repeated in the <strong>28th</strong> and <strong>36th</strong> week</span></li>\n<li><span><strong>Urine</strong> is tested <strong>(dipstick)</strong> for protein and sugar at <strong>every</strong> antenatal <strong>visit.</strong></span></li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p><span><strong>Fetal investigations</strong></span></p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<p><span><strong>Biophysical profile/Manning’s score:</strong></span></p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Parameters</strong></span></td>\n<td><span><strong>Minimal Normal Criteria</strong></span></td>\n<td><span><strong>Score</strong></span></td>\n</tr>\n<tr>\n<td><span>Non-stress Test (NST)  </span></td>\n<td><span>≥2 accelerations within 20-40 minutes.</span></td>\n<td><span>2</span></td>\n</tr>\n<tr>\n<td><span>Fetal breathing movements  </span></td>\n<td><span>≥ 1 episode of rhythmic breathing lasting &gt; 30 seconds.</span></td>\n<td><span>2</span></td>\n</tr>\n<tr>\n<td><span>Gross body movements  </span></td>\n<td><span>≥ 3 discrete body/limb movements</span></td>\n<td><span>2</span></td>\n</tr>\n<tr>\n<td><span>Fetal muscle tone  </span></td>\n<td><span>≥ 1 episode of active extension(limb or trunk) with return of flexion.</span></td>\n<td><span>2</span></td>\n</tr>\n<tr>\n<td><span>Amniotic fluid volume</span></td>\n<td><span>A pocket of amniotic fluid that measures at least 2 cm in two perpendicular planes (2×2 cm pocket)</span></td>\n<td><span>2</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li><span>Observation for 30 minutes</span></li>\n<li><span>Normal score- 2; Abnormal- 0</span></li>\n</ul>\n<p><span>Interpretation and management of BPP scores:</span></p>\n<p><span><strong>Modified Biophysical profile</strong></span></p>\n<div class=\"page\" title=\"Page 144\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span>It consists of NST and amniotic fluid index (AFI). Modified BPP is considered abnormal when the NST is non-reactive and/ or the AFI is &lt; 5.</span></p>\n</div>\n</div>\n</div>\n</div>\n<p><span><strong>Cardiotocograph</strong></span></p>\n<p><span><strong>Normal</strong> <strong>baseline fetal heart rate</strong> (FHR) is <strong>110-160 bpm</strong> (beats per minute). Baseline FHR shows a <strong>beat-to-beat fluctuation</strong> in amplitude and frequency ranging from<strong> 5-25 bpm</strong>. This is called <strong>baseline variability. </strong></span></p>\n<p><span><strong>1. Acceleration:</strong> Transient <strong>increase in fetal heart rate </strong>(FHR) by <strong>15 bpm</strong> or more, lasting for <strong>at least 15 seconds</strong>. It denotes intact neurohormonal and cardiovascular activity and, therefore, a <strong>healthy fetus</strong>.</span></p>\n<p><span><strong>2. Deceleration</strong>: Transient <strong>decrease in FHR </strong>below the baseline by<strong> 15 bpm</strong> or more and <strong>lasting ≥15 seconds</strong>. Three basic types of deceleration are early, late, and variable:</span></p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Feature</strong></span></td>\n<td><span><strong>Early deceleration/Type I Dips</strong></span></td>\n<td><span><strong>Late deceleration/</strong><strong>Type II Dips</strong></span></td>\n<td><span><strong>Variable deceleration</strong></span></td>\n</tr>\n<tr>\n<td><span>The pattern of heart rate fall</span></td>\n<td>\n<p><span><strong>Gradual decline </strong>and gradual recovery of heart rate.</span></p>\n<p><span>The maximum dip of the deceleration <strong>corresponds </strong>with the peak of the contraction. </span></p>\n</td>\n<td>\n<p><span><strong>Symmetrical </strong>and<strong> gradual decline </strong>in heart rate.</span></p>\n<p><span><strong>Begins after</strong> the onset of the uterine contraction.</span></p>\n<p><span>Onset, maximum dip, and recovery occur<strong> after</strong> the onset, peak, and recovery of contraction respectively.</span></p>\n</td>\n<td>\n<p><span><strong>Abrupt fall </strong>in the heart rate.   </span></p>\n<div class=\"page\" title=\"Page 596\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span>Decelerations are <strong>variable</strong> with respect to the size, shape, depth, duration, and timing of uterine contractions.</span></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><span>Time taken to reach the maximum dip of deceleration</span></td>\n<td><span> &gt;30seconds</span></td>\n<td><span> &gt;30seconds</span></td>\n<td><span> &lt;30 seconds</span></td>\n</tr>\n<tr>\n<td><span>Causes</span></td>\n<td><span><strong>Fetal head compression</strong></span></td>\n<td>\n<p><span>i) Placental pathology (postmaturity, hypertension, diabetes, <strong>placental abruption</strong>);</span></p>\n<p><span>(ii) <strong>Excessive uterine</strong> <strong>contractions</strong>;</span></p>\n<p><span>(iii) Injudicious use of oxytocin; (iv) Regional anesthesia (<strong>spinal</strong> or epidural)</span></p>\n</td>\n<td><span><strong>Umbilical cord compression</strong></span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e4661dee096f4ccf8f8a0a70fd8fc954x1279x856.JPEG\" alt=\"Explanation Image\"><p>For a Manning score of 8 with decreased AFV at 36 weeks of gestation delivery is done. Only if the gestational age is less than 36 weeks, there is scope for considering repeat testing.</p><hr><h3>Related Pearl: Deceleration patterns on cardiotocography (CTG)</h3><p><strong>Early deceleration</strong>: seen in head compression</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/01ca2f6239b443139c19f8cfb251123fx720x612.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Late deceleration</strong>:&nbsp;Seen in uteroplacental insufficiency, foetal hypoxia</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d22f1efb031f427abc29cb814976ea47x468x323.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Variable</strong> <strong>deceleration</strong>: Seen in umbilical cord compression</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/034553eba0b7498882645a4cf156f0e0x468x399.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0240",
      "difficulty": "hard"
    },
    {
      "text": "A patient presented to the OPD with recurrent hemoptysis and renal failure. Renal biopsy revealed crescents in most of the glomeruli. Immunofluorescence finding is shown in the image below. Which of the following is most commonly targetted in this disease?",
      "choices": [
        {
          "id": 1,
          "text": "α4 chains of collagen type IV"
        },
        {
          "id": 2,
          "text": "α3 chain of collagen type IV"
        },
        {
          "id": 3,
          "text": " α5 chain of collagen type IV"
        },
        {
          "id": 4,
          "text": "α2 chains of collagen  type IV"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario describes a patient with recurrent hemoptysis and renal failure, along with crescents on renal biopsy and linear immunofluorescence (IF) staining. These findings are characteristic of Goodpasture syndrome, in which antibodies are targeted against the <strong>α3 chain of collagen type IV.</strong></p>\n<p>In Goodpasture's syndrome, autoantibodies are directed against the <strong>α3 chain of type IV collagen</strong> found in the <strong>glomerular and alveolar basement membranes. </strong>This leads to a <strong>type II hypersensitivity reaction</strong>, which causes <strong>pulmonary hemorrhage</strong>, leading to hemoptysis, and r<strong>apidly progressive glomerulonephritis</strong>, which leads to renal failure.</p>\n<p>Renal immunofluorescence studies: In <strong>rapidly progressive glomerulonephritis (RPGN) type I</strong> and <strong>Goodpasture syndrome</strong>, immunofluorescence reveals a <strong>linear pattern</strong> (as shown below), which is a classic feature of anti–glomerular basement membrane disease (anti-GBM) disease. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/29dedbfc4c1745ccb3785f8084588164x850x640.PNG\" alt=\"Explanation Image\"><p>Below are various immunofluorescence patterns observed. The image shows <strong>negative immunofluorescence</strong>, indicative of <strong>minimal change disease.</strong> There are <strong><span>no Ig or complement deposits.</span></strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3ccfad59940b4e2faf1df988157984bax609x454.JPEG\" alt=\"Explanation Image\"><p><strong>Granular appearance</strong> on immunofluorescence microscopy is shown below, which is seen in:</p>\n<ul>\n<li><strong>Post-streptococcal glomerulonephritis: </strong><span>Immunofluorescent stain demonstrates discrete, coarsely </span><strong>granular deposits</strong><span> of complement protein </span><strong>C3</strong><span> and </span><strong>IgG</strong><span> corresponding to “humps”.</span></li>\n<li><span><strong>Rapidly Progressive Glomerulonephritis Type II:</strong> It is <strong>immune-complex</strong> mediated and shows <strong>granular</strong> deposits on the immunofluorescent stain.</span></li>\n<li><span><strong>Membranoproliferative glomerulonephritis (MPGN) Type I</strong>: I</span><span>mmunofluorescence shows <strong>IgG</strong> and <strong>C3</strong> and <strong>early complement</strong> components(C1q and C4) <strong>deposited</strong> in a granular pattern.</span></li>\n<li><span><strong>Membranous nephropathy</strong>: Immunofluorescence microscopy demonstrates that the <strong>granular deposits</strong> contain both immunoglobulins and complement.</span></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5550ad882aed43afb9291b09016da4cbx986x728.JPEG\" alt=\"Explanation Image\"><p><strong>Lupus nephritis: </strong>Immunofluorescence staining of the kidney biopsy specimen shows positive staining for fibrinogen, IgG, IgA, IgM, C1q, C3, λ chain, and k light chain. This is known as a <strong>full-house effect</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d6c5197f2358421984f32332d40dedcdx1280x1137.JPEG\" alt=\"Explanation Image\"><p><strong>IgA nephropathy:</strong> Immunofluorescence microscopy<span> shows <strong>IgA</strong> <strong>deposition </strong>in the <strong>mesangium.</strong></span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5fe8f0fb5ded4459b59ab141165a20c1x1280x1133.JPEG\" alt=\"Explanation Image\"><p>Membranoproliferative glomerulonephritis type 2 (<strong>MPGN type 2</strong>) or <strong>dense-deposit disease: </strong>Immunofluorescence shows <span><strong>C3 deposition</strong> in irregular granular or linear foci in the basement membranes on either side <strong>but not within</strong> the dense <strong>deposits.</strong></span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ac4142a241d54d55b0e0c99601a32e29x1280x1329.JPEG\" alt=\"Explanation Image\"><div class=\"page\" title=\"Page 918\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Focal segmental glomerulosclerosis</strong>: Immunofluorescence microscopy shows <strong>IgM</strong> and <strong>C3 deposition</strong> in the sclerotic areas and/or in the mesangium.</p>\n<p>Other options</p>\n<p>Option A: A Mutation in the <strong>α4 chains of collagen type IV</strong> is seen in <strong>thin basement membrane nephropathy.</strong></p>\n<p>Option C: A Mutation in the <strong>α5 chain of collagen type IV</strong> is seen in <strong>Alport syndrome.</strong></p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Glomerular Pathology in Renal Diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td><strong>Light microscopy</strong></td>\n<td><strong>Fluorescence microscopy</strong></td>\n<td>\n<p><strong>Electron microscopy</strong></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p>Nephritic syndrome:</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Postinfectious glomerulo-nephritis</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Diffuse endocapillary proliferation; leukocytic infiltration</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Granular IgG and C3 in glomerular basement membrane and mesangium,&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Granular IgA in some cases</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Subepithelial humps </strong>Subendothelial deposits in early disease stages</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Goodpasture syndrome</p>\n</td>\n<td>Extracapillary proliferation with <strong>crescents</strong>; necrosis</td>\n<td>&nbsp;<strong>Linear </strong>IgG and C3; fibrin in crescents</td>\n<td>\n<p><strong>Linear deposits</strong><strong><strong>&nbsp;</strong></strong>along the basement membrane.&nbsp;</p>\n<p><strong>Disruptions in GBM</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IgA nephropathy (Berger disease)</p>\n</td>\n<td>Focal mesangial proliferative glomerulo-nephritis; mesangial widening</td>\n<td>&nbsp;<strong>IgA</strong> &plusmn; IgG, IgM, and C3 in mesangium</td>\n<td><strong>Mesangial </strong>and paramesangial dense deposits&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Alport syndrome</p>\n</td>\n<td>Normal</td>\n<td>Negative</td>\n<td><strong>Basket-weave appearance </strong>of GBM</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p>Nephrotic syndrome:</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membranous&nbsp; nephropathy</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Diffuse capillary wall thickening</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Granular IgG and C3; diffuse</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Subepithelial deposits </strong>(epimembranous spikes),&nbsp;effacement of podocyte&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Minimal change disease</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal; lipid in tubules</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Negative&nbsp;</td>\n<td>\n<p>No deposits.</p>\n<p>Effacement of podocyte&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Focal segmental glomerulo-sclerosis&nbsp; (FSGS)</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Glomerular hyalinosis and sclerosis</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>Occasional C3 and IgM deposits in the sclerotic areas and the mesangium.</td>\n<td>\n<p>No deposits.</p>\n<p>Effacement of podocyte&nbsp;</p>\n<p>Epithelial denudation.</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p>Nephrito-nephrotic syndrome:&nbsp;&nbsp;&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Membrano-proliferative glomerulo-nephritis</p>\n<p>(MPGN) type I</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mesangial proliferative pattern of proliferation; GBM thickening; splitting</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>C3, C1q, C4 deposits&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\nIgG deposits</td>\n<td>\n<p><strong>Subendothelial deposits</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dense-deposit disease (MPGN type II)</p>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mesangial proliferative&nbsp; pattern of proliferation; GBM thickening; splitting</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 915\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>C3 deposits;</p>\n<p>No C1q and C4 deposits</p>\n<p>No IgG deposits</p>\n</div>\n</div>\n</div>\n</div>\n&nbsp;</td>\n<td>\n<p><strong>Intramembranous </strong>Dense deposits</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Fibrillary glomerulo-nephritis</p>\n</td>\n<td>&nbsp;\n<div class=\"page\" title=\"Page 931\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Membrano-proliferative or mesangio-proliferative patterns</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>IgG4 and C3&nbsp;</td>\n<td>Fibrillar deposits in the mesangium and capillary walls</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Note:</p>\n<ul>\n<li>Anionic antigens form subendothelial deposits.</li>\n<li>Cationic antigens form subepithelial deposits.</li>\n<li>Neutral antigens form mesangial deposits.</li>\n</ul>\n<p>&nbsp;</p><hr><h3>Related Pearl: Sites of Deposits in Glomerular diseases</h3><table>\n<tbody>\n<tr>\n<td><strong>Subepithelial</strong></td>\n<td>\n<ul>\n<li>Membranous nephropathy (epimembranous)</li>\n<li>PSGN</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Intramembranous</strong></td>\n<td>\n<ul>\n<li>Dense deposit disease (MPGN type II)</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Subendothelial</strong></td>\n<td>\n<ul>\n<li>MPGN Type I</li>\n<li>Lupus nephritis class III and IV</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Mesangial</strong></td>\n<td>\n<ul>\n<li>IgA nephropathy</li>\n<li>Henoch&ndash;Schonlein Purpura</li>\n<li>RPGN&nbsp;</li>\n<li>Lupus nephritis classes I and II</li>\n<li>Resolving postinfectious&nbsp; glomerulonephritis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>No deposits</strong></td>\n<td>\n<ul>\n<li>Minimal change disease</li>\n<li>FSGS</li>\n<li>Alport syndrome</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>MPGN: Membranoproliferative glomerulonephritis</p>\n<p>PSGN: Poststreptococcal glomerulonephritis&nbsp;</p>\n<p>FSGS: Focal segmental glomerulosclerosis</p>\n<p>RPGN: Rapidly progressive glomerulonephritis&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7a297a03f6db49959196ff715d59b609x1280x1685.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Nephrotic and nephritic syndromes</h3><table class=\"t1\">\n<tbody>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p3\">&nbsp;</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Nephrotic Syndrome</strong></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Nephritic Syndrome</strong> (Glomerulonephritis)</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Primary pathology</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Damage and dysfunction of glomerular filtration barrier, causing significant leakage of plasma proteins without much glomerular inflammation</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Significant inflammatory injury of the glomerulus resulting in passage of RBCs, inflammatory cells &amp; plasma proteins</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">The principal site of glomerular injury</p>\n</td>\n<td class=\"td1\" valign=\"top\">Visceral epithelial cell (Podocyte)</td>\n<td class=\"td1\" valign=\"top\">Endothelial cells, glomerular basement membrane (GBM), Mesangial cells, Parietal epithelial cells (&gt;Crescents)</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Clinical features</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Hallmark: </strong></p>\n<p class=\"p1\"><strong>Heavy Proteinuria: 3.5 g</strong>/24 h or Urine protein:creatinine ratio &gt;3)<span class=\"Apple-converted-space\">&nbsp; </span></p>\n<p class=\"p1\">Hypoalbuminemia,<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p class=\"p1\">Edema</p>\n<p class=\"p1\">Lipiduria, Hyperlipidemia</p>\n<p class=\"p1\">Microscopic hematuria</p>\n<p class=\"p1\">Hypertension</p>\n<p class=\"p1\">Hypercoagulability<span class=\"Apple-converted-space\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</span></p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\"><strong>Hallmark: </strong></p>\n<p class=\"p1\"><strong>Hematuria</strong> (RBC casts/dysmorphic RBCs)</p>\n<p class=\"p1\">Varying degrees of proteinuria and pyuria</p>\n<p class=\"p1\">Renal dysfunction</p>\n<p class=\"p1\">Hypertension</p>\n</td>\n</tr>\n<tr>\n<td class=\"td1\" valign=\"top\">\n<p class=\"p1\">Associated Glomerular pathology</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p>Minimal change disease (Primary and secondary)</p>\n<p>Focal segmental glomerulosclerosis (FSGS) (Primary and secondary)</p>\n<p>Membranous-nephropathy (Primary and secondary)</p>\n<p>Diabetic nephropathy</p>\n<p>Amyloidosis</p>\n</td>\n<td class=\"td1\" valign=\"top\">\n<p>Acute post-streptococcal glomerulonephritis</p>\n<p>Rapidly progressive glomerulonephritis (crescentic)</p>\n<p>IgA nephropathy (Berger disease)</p>\n<p>Membranoproliferative glomerulonephritis</p>\n<p>Alport syndrome</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"p1\">These syndromes, however, are <strong>not mutually exclusive</strong>. Some glomerular diseases <strong>may progress from one pattern to another</strong> or&nbsp;may present with considerable<strong> overlap</strong> between them, as&nbsp;a <strong>nephritic&ndash;nephrotic syndrome;</strong>&nbsp;features of nephrotic syndrome can concurrently occur with any form of nephritic syndrome but are most commonly seen with diffuse proliferative glomerulonephritis (seen in systemic lupus erythematosus) and membranoproliferative glomerulonephritis.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a9d0f863265d4c33b7e08835ca4e952d.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0244",
      "difficulty": "medium"
    },
    {
      "text": "Identify the cell in the peripheral smear given below and the condition it is elevated.",
      "choices": [
        {
          "id": 1,
          "text": "Lymphocyte, Infectious mononucleosis"
        },
        {
          "id": 2,
          "text": "Monocyte, Malaria"
        },
        {
          "id": 3,
          "text": "Eosinophil, Asthma"
        },
        {
          "id": 4,
          "text": "Basophil, Chronic myeloid leukemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span>The peripheral smear shows coarse, deep red staining granules in the cytoplasm with two nuclear lobes suggestive of <strong>eosinophil.&nbsp;</strong>They are elevated in <strong>asthma.</strong></span></p>\n<p><span><strong>WBC parameters:</strong></span></p>\n<p><span><strong>1) WBC count</strong></span></p>\n<p><span>a) Normal range</span></p>\n<div class=\"page\" title=\"Page 192\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><span>Adults: 4,000 &ndash; 11,000/&mu;l</span></li>\n<li><span>Infants at birth: 10,000- 26,000/&mu;l</span></li>\n<li><span>Children under 1 year: 6,000 &ndash; 18,000/&mu;l</span></li>\n</ul>\n<p><span>b) Differential count</span></p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Type of cell</strong></span></td>\n<td><span><strong>Description</strong></span></td>\n<td><span><strong>Increase in cell count</strong></span></td>\n<td><span><strong>Decrease in cell count</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Neutrophils</strong></span></td>\n<td>\n<p><span>They have a characteristic dense <strong>nucleus,</strong> having <strong>2-5 lobes</strong> and pale cytoplasm containing numerous fine <strong>violet-pink granules.</strong></span></p>\n<div class=\"page\" title=\"Page 201\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span>&nbsp;</span></p>\n<p><span>&nbsp;</span></p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p><span>An <strong>increase</strong> in neutrophil count above <strong>7,500/&mu;l</strong> is called <strong>neutrophilia</strong>&nbsp;</span></p>\n<div class=\"page\" title=\"Page 201\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>Acute infections</strong></span></p>\n<ul>\n<li><span>Pneumonia</span></li>\n<li><span>Acute appendicitis</span></li>\n<li><span>Acute cholecystitis</span></li>\n<li><span>Salpingitis</span></li>\n<li><span>Peritonitis</span></li>\n<li><span>Abscess</span></li>\n</ul>\n<p><span><strong>Intoxication</strong></span></p>\n<ul>\n<li><span>Uraemia</span></li>\n<li><span>Diabetic ketosis</span></li>\n<li><span>Poisoning by chemicals</span></li>\n<li><span>Eclampsia</span></li>\n</ul>\n<p><span><strong>Inflammation from tissue damage</strong></span></p>\n<ul>\n<li><span>Burns</span></li>\n<li><span>Ischaemic necrosis</span></li>\n<li><span>Gout</span></li>\n<li><span>Hypersensitivity reaction</span></li>\n</ul>\n<p><span><strong>Acute haemorrhage</strong></span></p>\n<p><span><strong>Neoplastic conditions</strong></span></p>\n<ul>\n<li><span>Myeloid leukemia (CML)</span></li>\n<li><span>Polycythaemia vera</span></li>\n<li><span>Myelofibrosis</span></li>\n<li><span>Disseminated cancers</span></li>\n</ul>\n</div>\n</div>\n<div class=\"layoutArea\"><span>&nbsp;</span></div>\n</div>\n</td>\n<td>\n<p><span>A <strong>fall</strong> in neutrophil count below <strong>2,000/&mu;l</strong> is termed <strong>neutropenia</strong></span></p>\n<div class=\"page\" title=\"Page 201\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>Infections</strong></span></p>\n<ul>\n<li><span>Typhoid</span></li>\n<li><span>Brucellosis</span></li>\n<li><span>Measles</span></li>\n<li><span>Malaria</span></li>\n<li><span>Kala-azar</span></li>\n<li><span>Miliary tuberculosis</span></li>\n</ul>\n<p><span><strong>Drugs, chemicals, and physical agents </strong></span></p>\n<ul>\n<li><span>Antimetabolites</span></li>\n<li><span>Benzene</span></li>\n<li><span>Nitrogen mustard</span></li>\n<li><span>Irradiation</span></li>\n</ul>\n<p><span><strong>Hematological and other diseases</strong></span></p>\n<ul>\n<li><span>Aplastic anemia</span></li>\n<li><span>Pernicious anemia</span></li>\n<li><span>SLE</span></li>\n<li><span>Gaucher&rsquo;s disease</span></li>\n<li><span>Cachexia</span></li>\n<li><span>Anaphylactic shock</span></li>\n</ul>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Lymphocytes</strong></span></td>\n<td>\n<p><span>They have a <strong>round</strong> or slightly indented <strong>nucleus</strong> with coarsely clumped chromatin and <strong>scanty</strong> basophilic and <strong>agranular cytoplasm.</strong></span></p>\n</td>\n<td>\n<p><span>An absolute lymphocyte count of more than <strong>4,000/&mu;l</strong> is termed lymphocytosis.&nbsp;</span></p>\n<div class=\"page\" title=\"Page 202\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>Acute Infections</strong></span></p>\n<ul>\n<li><span>Pertussis</span></li>\n<li><strong><span>Infectious mononucleosis</span></strong></li>\n<li><span>Viral hepatitis</span></li>\n</ul>\n<p><span><strong>Chronic Infections</strong></span></p>\n<ul>\n<li><span>Tuberculosis</span></li>\n<li><span>Brucellosis</span></li>\n<li><span>Secondary syphilis</span></li>\n</ul>\n<p><span><strong>Hematopoietic Disorders</strong></span></p>\n<ul>\n<li><span>CLL</span></li>\n<li><span>NHL</span></li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p><span>An absolute lymphocyte count below <strong>1,500/&mu;l</strong> is called lymphopenia.</span></p>\n<div class=\"page\" title=\"Page 202\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><span>Aplastic anemia</span></li>\n<li><span>High dose of steroid administration</span></li>\n<li><span>AIDS</span></li>\n<li><span>Hodgkin&rsquo;s disease</span></li>\n<li><span>Irradiation</span></li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><span><strong>Monocytes</strong></span></td>\n<td>\n<p><span>It is the largest mature leucocyte. It possesses a <strong>horseshoe-shaped nucleus</strong> which has a characteristically fine reticulated chromatin network. The <strong>cytoplasm</strong> is abundant, <strong>pale</strong> blue, and contains many fine granules and <strong>vacuoles.</strong></span></p>\n</td>\n<td>\n<p><span>A rise in absolute monocyte count <strong>above 800/&mu;l</strong> is called monocytosis</span></p>\n<div class=\"page\" title=\"Page 202\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>Bacterial infections</strong></span></p>\n<ul>\n<li><span>Tuberculosis</span></li>\n<li><span>SABE</span></li>\n<li><span>Syphilis</span></li>\n</ul>\n<p><span><strong>Protozoal infections</strong></span></p>\n<ul>\n<li><strong><span>Malaria</span></strong></li>\n<li><span>Kala-azar</span></li>\n<li><span>Trypanosomiasis</span></li>\n</ul>\n<p><span><strong>Hematopoietic disorders</strong></span></p>\n<ul>\n<li><span>Monocytic leukemia</span></li>\n<li><span>Hodgkin&rsquo;s disease</span></li>\n<li><span>Multiple myeloma</span></li>\n<li><span>Myeloproliferative disorders</span></li>\n</ul>\n</div>\n</div>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>Miscellaneous conditions</strong></span></p>\n<ul>\n<li><span>Sarcoidosis</span></li>\n<li><span>Cancer of the ovary, breast, stomach</span></li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><span>&nbsp;</span></td>\n</tr>\n<tr>\n<td><span><strong>Eosinophil</strong></span></td>\n<td>\n<p><span>Eosinophil has coarse, deep <strong>red</strong> staining granules in the cytoplasm and has usually <strong>two nuclear lobes</strong> in the form of a spectacle.</span></p>\n<div class=\"page\" title=\"Page 202\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span>&nbsp;</span></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p><span>An increase in the absolute eosinophil count <strong>above 400/&mu;l</strong> is termed eosinophilia</span></p>\n<div class=\"page\" title=\"Page 203\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>Allergic disorders</strong>: <strong>Asthma,</strong> urticaria</span></p>\n<div class=\"page\" title=\"Page 203\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>Parasitic infestations</strong>: Hookworm, Roundworm</span></p>\n<div class=\"page\" title=\"Page 203\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>Skin diseases:</strong> Pemphigus, Dermatitis herpetiformis</span></p>\n<div class=\"page\" title=\"Page 203\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>Pulmonary diseases:</strong> Loeffler's syndrome, Tropical eosinophilia</span></p>\n<div class=\"page\" title=\"Page 203\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>Hematopoietic diseases:</strong> CML, Polycythemia vera</span></p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td><span>Eosinopenia can be seen in <strong>steroid administration</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Basophil</strong></span></td>\n<td>\n<p><span>Basophils contain coarse, intensely <strong>basophilic granules</strong> which usually fill the cytoplasm and often overlap and <strong>obscure</strong> the <strong>nucleus.</strong></span></p>\n<div class=\"page\" title=\"Page 202\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span>&nbsp;</span></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p><span>Basophilia refers to an increase in the absolute basophil count <strong>above 100/&mu;l</strong></span></p>\n<ul>\n<li><strong><span>Chronic myeloid leukemia</span></strong></li>\n<li><span>Polycythaemia vera</span></li>\n<li><span>Myxoedema</span></li>\n<li><span>Ulcerative colitis</span></li>\n<li><span>Hodgkin&rsquo;s disease</span></li>\n<li><span>Urticaria pigmentosa</span></li>\n</ul>\n</td>\n<td><span>&nbsp;</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><span><strong>2) Platelet count</strong></span></p>\n<table>\n<tbody>\n<tr>\n<td><span><strong>Name</strong></span></td>\n<td><span><strong>Normal range</strong></span></td>\n<td><span><strong>Conditions causing thrombocytopenia&nbsp;</strong></span></td>\n<td><span><strong>Conditions causing thrombocytosis</strong></span></td>\n</tr>\n<tr>\n<td><span>Platelet count</span></td>\n<td><span>1,50,000-400,000/&mu;l</span></td>\n<td>\n<p><span><strong>Impaired platelet production:</strong></span></p>\n<ul>\n<li><span>Aplastic anemia</span></li>\n<li><span>Acute leukemias</span></li>\n<li><span>Myelofibrosis</span></li>\n<li><span>Marrow infiltration by malignancy</span></li>\n<li><span>Drugs(e.g.chloramphenicol,thiazides, anticancer drugs)</span></li>\n<li><span>Chronic alcoholism</span></li>\n</ul>\n<div class=\"page\" title=\"Page 194\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><span><strong>Accelerated platelet destruction:</strong></span></p>\n<div class=\"page\" title=\"Page 194\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li><span>ITP</span></li>\n<li><span>SLE</span></li>\n<li><span>AIDS</span></li>\n<li><span>CLL</span></li>\n<li><span>DIC</span></li>\n<li><span>Giant haemangioma</span></li>\n<li><span>Drug-induced(e.g.sulfonamides,quinine,gold)</span></li>\n<li><span>Microangiopathichaemolyticanaemia</span></li>\n<li><span>Splenomegaly</span></li>\n<li><span>Massive transfusion of blood</span></li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<ul>\n<li><span>Essential thrombocytosis</span></li>\n<li><span>Chronic infection</span></li>\n<li><span>Hemorrhage</span></li>\n<li><span>Postoperative state</span></li>\n<li><span>Malignancy</span></li>\n<li><span>Post-splenectomy</span></li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4dd3d0ad09334aa0b87cc0469743a1ce.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0299",
      "difficulty": "medium"
    },
    {
      "text": "A 65-year-old male presents with complaints of easy fatigability, weight loss, and an evening rise in temperature. Investigations reveal pancytopenia. The bone marrow aspirate of a patient is shown in the image given below. Cytogenetic studies revealed the presence of t(15:17). This subtype of disease is associated with which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Chloroma"
        },
        {
          "id": 2,
          "text": "DIC"
        },
        {
          "id": 3,
          "text": "Leukemia cutis"
        },
        {
          "id": 4,
          "text": "Down's syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the given clinical scenario, the presence of <strong>Auer rods</strong> on bone marrow aspirates and <strong>t(15:17)</strong> on cytogenic studies points towards the diagnosis of <strong>AML-M3. DIC</strong> is most <strong>commonly associated</strong> with AML-M3.</p>\n<p><strong>Peripheral smear (WBC):</strong></p>\n<p><strong>1) Acute myeloid leukemia</strong></p>\n<p>Acute myeloid leukemia is a tumor of hematopoietic progenitors caused by acquired oncogenic mutations. This leads to the accumulation of immature myeloid blasts in the marrow resulting in marrow failure and complications related to anemia, thrombocytopenia, and neutropenia.</p>\n<ul>\n<li>Bone marrow/peripheral smear shows a large, uniform population of cells <strong>(myeloblasts)</strong> with prominent nucleoli (<strong>yellow arrow</strong>). It shows the presence of primary cytoplasmic granules</li>\n<li><strong>Auer rods: Needle-shaped</strong> azurophilic intracytoplasmic <strong>inclusion bodies(black arrow</strong>) particularly seen in <strong>acute promyelocytic leukemia</strong> (AML M3) with <strong>t(15;17).</strong></li>\n</ul>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2d5a413779f1468dac68342811b4bb48x352x512.JPEG\" alt=\"Explanation Image\"><p><strong>2) Acute lymphoblastic leukemia (ALL)</strong> </p>\n<p>ALL arises from immature B (pre-B) or T (pre-T) cells called <strong>lymphoblasts. Immunohistochemistry</strong> for terminal deoxynucleotidyl transferase <strong>(TdT)</strong> is positive in pre-B and pre-T lymphoblasts. Peripheral smear shows lymphoblasts that have condensed chromatin, less conspicuous nucleoli, and scant basophilic cytoplasm which lacks granules as shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9788bbf7ca0b4bf092835c95fb655bdex720x820.JPEG\" alt=\"Explanation Image\"><p><strong>3) Chronic lymphocytic leukemia (CLL)</strong></p>\n<p>CLL is associated with the <strong>deletions</strong> of 13q, 11q, 17q, and trisomy 12q. Lymph nodes are diffusely effaced by small lymphocytes with <strong>proliferation centers</strong>. The peripheral smear shows small round lymphocytes with scant cytoplasm and <strong>smudge cells</strong> as seen below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3ea50c0952f847bb8c23e2a4ef34546ax355x512.JPEG\" alt=\"Explanation Image\"><p><strong>4) Chronic myeloid leukemia (CML)</strong></p>\n<p>CML is characterized by the presence of a<strong> Philadelphia chromosome </strong>resulting from reciprocal translocation t(9;22) forming the<strong> BCR-ABL fusion </strong>gene. They have hypercellular marrow due to a massively increased number of maturing granulocytic precursors. The image below shows peripheral smear findings of CML with neutrophils, myelocytes, metamyelocytes, and band cells.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a07b0a55e0f04edfaefe10bde3ca73c7x1280x960.JPEG\" alt=\"Explanation Image\"><p>Other options</p>\n<p>Option A: Chloroma( localised soft tissue mass composed of extramedullary proliferation of primitive cells of myeloid lineage) is commonly associated with AML-M2. It can also be seen in AML-M4 and M5</p>\n<p>Option C: Leukemia cutis(leukemic infiltration of the epidermis, the dermis, and the subcutaneous tissue.). is associated with AML-M4 and M5.</p>\n<p>Option D: Down's syndrome is associated with AML-M7.</p>\n<p> </p><hr><h3>Related Pearl: FAB classification</h3><table>\n<tbody>\n<tr>\n<td><strong>FAB classification</strong></td>\n<td><strong>High-Yield points</strong></td>\n</tr>\n<tr>\n<td>M0-minimal differentiation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M1-without maturation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M2 - with maturation</td>\n<td>\n<ul>\n<li>Most common</li>\n<li>t(8,21)</li>\n<li>Chloromas</li>\n<li>Good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M3 - promyelocytic</td>\n<td>\n<ul>\n<li>Young-good prognosis</li>\n<li>t(15,17)-intermediate</li>\n<li>Auer rods</li>\n<li>DIC</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M4 - myelomonocytic</td>\n<td>\n<ul>\n<li>inv 16</li>\n<li>t(16,16)</li>\n<li>Eosinophilia</li>\n<li>Gingival hyperplasia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>M5a - monoblastic</p>\n<p>M5b - monocytic</p>\n</td>\n<td>\n<ul>\n<li>Organ infiltration</li>\n<li>Gingival hyperplasia</li>\n<li>Increased WBC count, fever</li>\n<li>Sweet syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M6 - erythroid</td>\n<td>\n<ul>\n<li>Therapy related</li>\n<li>Erythemic myelosis, Di&nbsp;Guglielmo disease</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M7 - megakaryocytic</td>\n<td>\n<ul>\n<li>CD 41/61</li>\n<li>Bad prognosis</li>\n<li>Down syndrome (good prognosis)</li>\n<li>Bone marrow fibrosis (increased PDGF)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b0434874a75a4f368cec836760ac1c98.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0295",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following indicates the window phase of hepatitis B?<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>Lab findings</td>\n<td><strong>HBsAg</strong></td>\n<td><strong>Anti-HBs</strong></td>\n<td><strong>HBeAg</strong></td>\n<td><strong>Anti-HBe</strong></td>\n<td><strong>Anti-HBc</strong></td>\n</tr>\n<tr>\n<td>1</td>\n<td>+ </td>\n<td> -</td>\n<td>+ </td>\n<td>- </td>\n<td>IgM</td>\n</tr>\n<tr>\n<td>2</td>\n<td> -</td>\n<td>- </td>\n<td>+/-</td>\n<td>+/-</td>\n<td>IgM</td>\n</tr>\n<tr>\n<td>3</td>\n<td>+ </td>\n<td>- </td>\n<td>+  </td>\n<td>- </td>\n<td>IgG</td>\n</tr>\n<tr>\n<td>4</td>\n<td>+</td>\n<td>- </td>\n<td>- </td>\n<td>+ </td>\n<td>IgG</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "3"
        },
        {
          "id": 2,
          "text": "4"
        },
        {
          "id": 3,
          "text": "2"
        },
        {
          "id": 4,
          "text": "1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div>The window phase of hepatitis B is indicated by<strong> lab finding 2.</strong></div>\n<div> </div>\n<div><strong>The window period</strong> is a phase where even though hepatitis infection is present, <strong>HBsAg is non-reactive</strong>. Diagnosis is based on the <strong>presence of IgM Anti HBc</strong></div>\n<div> </div>\n<div><span>Serological Patterns of Hepatitis B Infection:</span></div>\n<div> </div>\n<div>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll answer-html ng-star-inserted\">\n<table>\n<tbody>\n<tr>\n<td><strong>Clinical phases</strong></td>\n<td><strong>HBsAg</strong></td>\n<td><strong>Anti-HBs</strong></td>\n<td><strong>HBeAg</strong></td>\n<td><strong>Anti-HBe</strong></td>\n<td><strong>Anti-HBc</strong></td>\n</tr>\n<tr>\n<td>Acute HBV</td>\n<td>+ </td>\n<td> -</td>\n<td>+ </td>\n<td>- </td>\n<td>IgM</td>\n</tr>\n<tr>\n<td><strong>Window period</strong></td>\n<td><strong> -</strong></td>\n<td><strong>- </strong></td>\n<td><strong>+/-</strong></td>\n<td><strong>+/-</strong></td>\n<td><strong>IgM</strong></td>\n</tr>\n<tr>\n<td>Chronic HBV(high infectivity)</td>\n<td>+ </td>\n<td>- </td>\n<td>+  </td>\n<td>- </td>\n<td>IgG</td>\n</tr>\n<tr>\n<td>Chronic HBV(low infectivity)</td>\n<td>+</td>\n<td>- </td>\n<td>- </td>\n<td>+ </td>\n<td>IgG</td>\n</tr>\n<tr>\n<td>Immunised (Vaccination)</td>\n<td>- </td>\n<td>+</td>\n<td>- </td>\n<td>- </td>\n<td> </td>\n</tr>\n<tr>\n<td>Hepatitis B in the remote past</td>\n<td>- </td>\n<td>-</td>\n<td> -</td>\n<td>+/- </td>\n<td>IgG</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n</div>\n</div>\n<div class=\"ng-star-inserted\">\n<div class=\"table-responsive font-weight-light answer-scroll answer-html ng-star-inserted\">\n<p> </p>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0282",
      "difficulty": "medium"
    },
    {
      "text": "You are the intern posted in the emergency department. You came across an ABG report given below. Which of the following is the most likely cause for this change?<div class='question-desc-html'><p>pH: 7.50<br />PaCO<sub>2</sub>: 28 mm of Hg<br />HCO<sub>3</sub><sup>-</sup>: 24 mEq/L</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Severe asthma"
        },
        {
          "id": 2,
          "text": "Renal tubular acidosis"
        },
        {
          "id": 3,
          "text": "Panic attack"
        },
        {
          "id": 4,
          "text": "Vomiting"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given ABG report shows increased blood arterial pH(Normal range: 7.35-7.45), decreased PaCO2(Normal: 35 - 45 mmHg) and normal HCO<sub>3</sub> levels(Normal: 22-28 mEq/L) indicating <strong>respiratory alkalosis.</strong>The most likely cause of respiratory alkalosis is <strong>panic disorder,</strong> which causes <strong>hyperventilation.</strong></p>\n<p><strong>Metabolic disorders</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Conditions</strong></td>\n<td><strong>Features</strong></td>\n<td><strong>Etiology</strong></td>\n</tr>\n<tr>\n<td><strong>Metabolic acidosis</strong></td>\n<td>\n<div class=\"page\" title=\"Page 402\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>There is <strong>decreased blood arterial pH</strong> because of an increase in endogenous acid production (Example: Diabetic ketoacidosis, increased lactate in sepsis), <strong>loss of HCO<sub>3</sub><sup>-</sup> </strong>(Example: diarrhoea), or low excretion of net acid by kidneys (Example: chronic kidney disease). Respiratory <strong>compensation</strong> (alveolar <strong>hyperventilation)</strong> occurs causing a <strong>decrease</strong> in <strong>PaCO<sub>2</sub>.</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p><strong>High anionic metabolic acidosis</strong></p>\n<ul>\n<li>Methanol</li>\n<li>Uremia</li>\n<li>Diabetic ketoacidosis</li>\n<li>Propylene glycol</li>\n<li>Iron tablets</li>\n<li>Lactic acidosis</li>\n<li>Ethylene glycol</li>\n<li>Salicylates <strong>(Late)</strong></li>\n</ul>\n<div class=\"page\" title=\"Page 402\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong><span>Normal anionic gap metabolic acidosis</span></strong></p>\n<ul>\n<li>Hyperalimentation</li>\n<li>Addison's disease</li>\n<li><strong>Renal tubular acidosis</strong></li>\n<li>Diarrhea</li>\n<li>Acetazolamide</li>\n<li>Spironolactone</li>\n<li>Saline infusion</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td><strong>Metabolic alkalosis</strong></td>\n<td>\n<div class=\"page\" title=\"Page 406\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>There is <strong>increased blood arterial pH</strong>, as a result of a <strong>net gain of HCO<sub>3</sub><sup>-</sup></strong> or a <strong>loss of nonvolatile acid</strong> from the extracellular fluid. <strong>Compensatory</strong> alveolar <strong>hypoventilation</strong> occurs and causes an <strong>increase</strong> in <strong>PaCO<sub>2</sub>.</strong> </p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>Loss of hydrogen:</p>\n<ul>\n<li>Gastrointestinal loss<br />\n<ul>\n<li>Removal of gastric secretions- <strong>vomiting</strong> or nasogastric suction</li>\n<li>Chloride-losing diarrhea</li>\n<li>Gastrocolic fistula</li>\n<li>Villous adenoma</li>\n<li>Antacid therapy, particularly if combined with cation exchange resin</li>\n</ul>\n</li>\n<li>Renal loss<br />\n<ul>\n<li>Loop or thiazide diuretics</li>\n<li>Mineralocorticoid excess (primary aldosteronism, Cushing's, steroids, licorice)</li>\n<li>Posthypercapnic states</li>\n<li>Hypercalcemia, including the milk-alkali syndrome</li>\n</ul>\n</li>\n<li>H<sup>+</sup> movement into cells\n<ul>\n<li>Hypokalemia</li>\n</ul>\n</li>\n</ul>\n<p>Exogenous Alkali:</p>\n<ul>\n<li>Administration of NaHCO3, sodium citrate/gluconate/acetate/antacids</li>\n<li>Massive blood transfusion</li>\n<li>Antacids- Milk alkali syndrome</li>\n</ul>\n<p>Contraction alkalosis (loss of ECF volume):</p>\n<ul>\n<li>Loop or thiazide-type diuretics</li>\n<li>Sweat losses in cystic fibrosis</li>\n<li>Gastric losses in achlorhydria</li>\n</ul>\n<p>Miscellaneous:</p>\n<ul>\n<li>Bartter's syndrome</li>\n<li>Gitelman's syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Respiratory acidosis</strong></td>\n<td>\n<p>There is <strong>decreased</strong> blood arterial <strong>pH</strong> as a result of an <strong>increase in PaCO</strong><sub><strong>2</strong> </sub>following <strong>alveolar hypoventilation</strong>.</p>\n</td>\n<td>\n<ul>\n<li><strong>Central:</strong> Stroke, infection</li>\n<li><strong>Airway:</strong> Obstruction, <strong>Asthma</strong></li>\n<li>Lung <strong>Parenchyma:</strong> Emphysema, Pneumoconiosis, Bronchitis</li>\n<li><strong>Neuromuscular:</strong> Muscular dystrophies, Myasthenia</li>\n<li>Obesity</li>\n<li>Hypoventilation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Respiratory alkalosis</strong></td>\n<td>\n<div class=\"page\" title=\"Page 409\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>There is an <strong>increase</strong> in blood arterial <strong>pH</strong> due to a <strong>decrease in PaCO<sub>2</sub></strong> due to <strong>alveolar hyperventilation.</strong></p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"page\" title=\"Page 408\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hyperventilation</strong></p>\n<ul>\n<li>Anxiety/<strong>panic attack</strong></li>\n<li>Hypoxemia( eg: High altitude)</li>\n<li>Salicylates <strong>(Early)</strong></li>\n<li>Pulmonary embolism</li>\n<li>Tumor</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cea77858973342d1816320d43c36b6b1x1280x1555.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Acid-Base Balance - Normal Values</h3><table>\n<tbody>\n<tr>\n<td>Component</td>\n<td>Normal Range</td>\n<td>Optimal Value</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.35 - 7.45</td>\n<td>7.4</td>\n</tr>\n<tr>\n<td>HCO<sub>3</sub><sup>-</sup>&nbsp;</td>\n<td>22 - 28 mEq/L&nbsp;</td>\n<td>&nbsp;24 mEq/L</td>\n</tr>\n<tr>\n<td>pCO<sub>2</sub></td>\n<td>35 - 45 mmHg</td>\n<td>40 mmHg&nbsp;</td>\n</tr>\n<tr>\n<td>Anion gap</td>\n<td>6 - 12 mEq/L</td>\n<td>&lt;10 mEq/L</td>\n</tr>\n<tr>\n<td>O<sub>2</sub> saturation</td>\n<td colspan=\"2\">&gt; 95%</td>\n</tr>\n<tr>\n<td>pO<sub>2</sub></td>\n<td colspan=\"2\">75 - 100 mmHg&nbsp;&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Interpretation of Acid-Base Disorders</h3><table>\n<tbody>\n<tr>\n<td>\n<p>pH&lt;7.35 is acidosis</p>\n<p>pH&gt;7.45 is alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in HCO<sub>3</sub><sup>-</sup> is termed metabolic</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is in keeping with the pH (i.e. if there are acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is decreased) the problem is metabolic.</p>\n<p>If the change in HCO<sub>3</sub><sup>-</sup>&nbsp;is opposite with the pH (i.e. if there is acidosis and HCO<sub>3</sub><sup>-</sup>&nbsp;is increased or normal) the problem is compensatory metabolic.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>A primary change in CO<sub>2 </sub>is termed as respiratory</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>If the change in CO<sub>2 </sub>keeping in line with the pH (if in acidosis CO2 is raised) the problem is termed respiratory</p>\n<p>If the change in CO<sub>2</sub> is in the opposite direction of that of the pH (i.e. if there&nbsp;are acidosis and CO<sub>2</sub> is decreased or normal ) the problem is termed compensatory respiratory</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Expected compensation in acid-base disorders</h3><table>\n<tbody>\n<tr>\n<td>Primary disorder</td>\n<td>Expected compensation</td>\n</tr>\n<tr>\n<td>Metabolic acidosis</td>\n<td>\n<p>Expected PaCO<sub>2</sub> = [1 .5 X HCO<sub>3</sub><sup>-</sup>] + 8 &plusmn; 2; or</p>\n<p>&darr; PaCO2 = 1.25 x &Delta;HCO3</p>\n</td>\n</tr>\n<tr>\n<td>Metabolic alkalosis</td>\n<td>Increase in PaCO<sub>2 </sub>= 0.75 x &Delta;HCO<sub>3</sub><sup>-</sup></td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Respiratory acidosis</p>\n</td>\n</tr>\n<tr>\n<td>Acute</td>\n<td>\n<p>Increase in HCO<sub>3</sub><sup>- </sup>= 0.1 x &Delta; PaCO<sub>2</sub></p>\n<p>&darr; pH = 0.008 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td>Chronic</td>\n<td>\n<p>Increase in HCO<sub>3</sub><sup>- </sup>= 0.4 x &Delta; PaCO<sub>2</sub></p>\n<p>&darr; pH = 0.003 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\">\n<p>Respiratory alkalosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acute</p>\n</td>\n<td>\n<p>Decrease in HCO<sub>3</sub><sup>- </sup>= 0.2 x &Delta; PaCO<sub>2</sub></p>\n<p>&uarr; pH = 0.008 x &Delta;PaCO2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chronic</p>\n</td>\n<td>\n<p>Decrease in HCO<sub>3</sub><sup>- </sup>= 0.4 x &Delta; PaCO<sub>2</sub></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0236",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented with a passage of cola-colored urine and abdominal pain. Flow cytometry of the blood of a patient revealed the following findings? Which of the following can be used in the management?<div class='question-desc-html'><p>Data of the Patient in Red<br />Data of Normal individual in Black</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Eculizumab"
        },
        {
          "id": 2,
          "text": "Emicizumab"
        },
        {
          "id": 3,
          "text": "Rituximab"
        },
        {
          "id": 4,
          "text": "Trastuzumab"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the given scenario, the history of the passage of cola-colored urine and abdominal pain with the flow cytogram showing a population of red blood cells <strong>deficient in both CD55 and CD59 </strong>is suggestive of <strong>paroxysmal nocturnal hemoglobinuria</strong> (PNH). <strong>Eculizumab </strong>can be used in the management of PNH.</p>\n<p>Есսlizumаb is a monoclonal antibody that binds to complement protein<strong> C5</strong>, preventing cleavage into C5a and C5b. Blocking the formation of C5b inhibits the subsequent formation of MAC.</p>\n<p>Other options</p>\n<p>Option B: <strong>Emicizumab </strong>is used in the management of hemophilia A.</p>\n<p>Option C: <strong>Rituximab</strong> is used in the management of CLL</p>\n<p>Option D: <strong>Trastuzumab</strong> is used in the management of breast cancer.</p>\n<p><strong>Flow cytometry </strong></p>\n<div class=\"page\" title=\"Page 341\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Flow cytometry is<span> used to <strong>identify cellular antigens</strong> expressed by tumors that arise from blood-forming tissues. These include B-cell and T-cell lymphomas and leukemias as well as myeloid neoplasms. </span><span>An advantage of flow cytometry over immunohistochemistry is that </span><strong>multiple antigens</strong><span> are </span><strong>assessed</strong><span> simultaneously.</span></p>\n<div class=\"page\" title=\"Page 342\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Below is the explanation of how to interpret flow cytometry results:</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6fdbee5356f744abb37f074deec0d402x1280x1080.JPEG\" alt=\"Explanation Image\"><p><strong>Interpretation</strong> of results:</p>\n<ul>\n<li>Quadrant <strong>1</strong>- Cells marked in green: <strong>-VE</strong> for <strong>A</strong> antigen, <strong>+VE</strong> for <strong>B</strong> antigen</li>\n<li>Quadrant <strong>2</strong>- Cells marked in purple: <strong>-VE</strong> for <strong>both</strong> the antigens.</li>\n<li>Quadrant <strong>3</strong>- Cells marked in yellow: <strong>+VE</strong> for <strong>both</strong> the antigens.</li>\n<li>Quadrant <strong>4</strong>- Cells marked in red: <strong>+VE</strong> for <strong>A</strong> antigen, <strong>-VE</strong> for <strong>B</strong> antigen</li>\n</ul><hr><h3>Related Pearl: Immune Cell Antigens Detected by Monoclonal Antibodies</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Immune cells</strong></p>\n</td>\n<td>\n<p><strong>Antigens associated</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T-cell</p>\n</td>\n<td>\n<p>CD1, CD3, CD4, CD5, CD8</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B-cell</p>\n</td>\n<td>\n<p>CD10, CD19, CD20, CD21, CD23, CD79a</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Monocyte or macrophage</p>\n</td>\n<td>\n<p>CD11c, CD13, CD14, CD15, CD33, CD64</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NK-cell</p>\n</td>\n<td>\n<p>CD16, CD56</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hematopoietic stem cells</p>\n</td>\n<td>\n<p>CD34</p>\n</td>\n</tr>\n<tr>\n<td>Leukocyte common antigen</td>\n<td>CD45</td>\n</tr>\n<tr>\n<td>Activated B cells, T cells, monocytes, and Reed-Sternberg cells</td>\n<td>CD30</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Origin of leukemia / lymphoma and their immunophenotypes</h3><table>\n<tbody>\n<tr>\n<td><strong>B cell precursors</strong></td>\n<td><strong>Derived lymphomas/leukemia</strong></td>\n<td><strong>Immunophenotype</strong></td>\n</tr>\n<tr>\n<td>Pro-B cell</td>\n<td>Pro-B cell ALL</td>\n<td>CD34,&nbsp;CD19, CD79a</td>\n</tr>\n<tr>\n<td>Pre-B cell</td>\n<td>Pre-B cell ALL</td>\n<td>CD19, CD79a,&nbsp;CD10, Tdt</td>\n</tr>\n<tr>\n<td>Mature B cell</td>\n<td>CLL/SLL</td>\n<td>\n<p>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD 23, CD5</p>\n</td>\n</tr>\n<tr>\n<td>Mantle zone</td>\n<td>Mantle zone lymphoma</td>\n<td>CD19, CD79a,CD 20, CD21, CD22, surface IgM, CD5</td>\n</tr>\n<tr>\n<td>Germinal center/Follicular center</td>\n<td>\n<p>Follicular lymphoma</p>\n<p>&nbsp;</p>\n<p>Diffuse large B-cell lymphoma</p>\n<p>Burkitt lymphoma</p>\n</td>\n<td>\n<p>CD 79a, CD 19, CD20, CD21,CD22, CD10, CD 23, Bcl-2</p>\n<p>CD10, Cd23, Bcl-6</p>\n<p>CD19, CD20, CD22, CD79a, CD10, Bcl-6</p>\n</td>\n</tr>\n<tr>\n<td>Memory B cells</td>\n<td>Extranodal marginal zone lymphoma</td>\n<td>CD19, CD79a,CD 20, surface Ig</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>CLL:&nbsp;Chronic lymphocytic leukemia&nbsp;</p>\n<p>SLL:&nbsp;Small lymphocytic lymphoma</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/2dc04b6078c64650a6e5d4f85e6ac9e9.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG0278",
      "difficulty": "easy"
    }
  ]
}